Header Logo

JOSEPH JANKOVIC

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Neurology
Address7200 CAMBRIDGE
Houston, TX 77030
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    U10NS044441     (JANKOVIC, JOSEPH)Sep 30, 2002 - Nov 30, 2015
    NIH
    Clinical center for the study of neuroprotection from PD
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ramanzini LG, Frare JM, Camargo LFM, Silveira JOF, Jankovic J. Does Delaying Levodopa Prevent Motor Complications in Parkinson's Disease? A Meta-Analysis. Mov Disord Clin Pract. 2024 Aug 27. PMID: 39189097.
      Citations:    Fields:    
    2. Okubadejo NU, Okun MS, Jankovic J. Tapping the Brakes on New Parkinson Disease Biological Staging. JAMA Neurol. 2024 Aug 01; 81(8):789-790. PMID: 38976240.
      Citations:    Fields:    Translation:Humans
    3. Dashtipour K, Sadeghi M, Charles D, Mehta S, Fernandez HH, Schwartz M, Jankovic J. Treatment response to onabotulinumtoxinA in cervical dystonia patients with anterocollis and retrocollis. Toxicon. 2024 Sep; 248:108035. PMID: 39059560.
      Citations:    Fields:    Translation:Humans
    4. Baizabal-Carvallo JF, Alonso-Juarez M, Jankovic J. Functional Neurological Disorders Among Patients With Tremor. J Neuropsychiatry Clin Neurosci. 2024 Jul 22; appineuropsych20230126. PMID: 39034668.
      Citations:    Fields:    
    5. Lenka A, Jankovic J. An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms. Expert Rev Neurother. 2024 Jul 21; 1-9. PMID: 39034647.
      Citations:    Fields:    
    6. Petramfar P, Jankovic J. Medication refractory restless legs syndrome: Real-world experience. J Neurol Sci. 2024 Aug 15; 463:123121. PMID: 38968665.
      Citations:    Fields:    Translation:Humans
    7. Yilmaz AY, Ruzicka E, Jankovic J. Leg stereotypy syndrome: phenomenological and quantitative analysis. J Neurol. 2024 Aug; 271(8):5519-5524. PMID: 38898269.
      Citations:    Fields:    Translation:Humans
    8. Lenka A, Jankovic J. Extrapyramidal System/Symptoms/Signs Should Be Retired. Neurol Clin Pract. 2024 Aug; 14(4):e200308. PMID: 38808022; PMCID: PMC11129327.
      Citations:    
    9. Jankovic J. Parkinson's Disease and Movement Disorders, 2nd Edition. Ann Indian Acad Neurol. 2024 May 01; 27(3):344. PMID: 38912544; PMCID: PMC11232831.
      Citations:    
    10. Anandan C, Jankovic J. Use of botulinum toxin in the management of dystonia in Parkinson's disease. Front Neurosci. 2024; 18:1371601. PMID: 38650620; PMCID: PMC11033361.
      Citations:    
    11. Mehanna R, Jankovic J. Systemic Symptoms in Huntington's Disease: A Comprehensive Review. Mov Disord Clin Pract. 2024 May; 11(5):453-464. PMID: 38529740; PMCID: PMC11078495.
      Citations: 1     Fields:    Translation:Humans
    12. Terravecchia C, Mostile G, Chisari CG, Rascun? C, Terranova R, Cicero CE, Giuliano L, Donzuso G, Sciacca G, Luca A, Preux PM, Jankovic J, Zappia M, Nicoletti A. Retinal Thickness in Essential Tremor and Early Parkinson Disease: Exploring Diagnostic Insights: Response. J Neuroophthalmol. 2024 Mar 11. PMID: 38466367.
      Citations:    Fields:    
    13. Cavanna AE, Baizabal-Carvallo JF, Jankovic J. Tics emergencies and malignant tourette syndrome: Assessment and management. Neurosci Biobehav Rev. 2024 Apr; 159:105609. PMID: 38447821.
      Citations:    Fields:    Translation:HumansPHPublic Health
    14. Jankovic J. Is Dystonia an Immunologic Disorder? Parkinsonism Relat Disord. 2024 May; 122:106084. PMID: 38462402.
      Citations:    Fields:    Translation:Humans
    15. Rodriguez-Porcel F, Sarva H, Joutsa J, Falup-Pecurariu C, Shukla AW, Mehanna R, Smilowska K, Lanza G, Filipovic SR, Shalash A, Ferris M, Jankovic J, Espay AJ, Pandey S, Post-Stroke Movement Disorders Study Group from the Movement Disorders Society. Current opinions and practices in post-stroke movement disorders: Survey of movement disorders society members. J Neurol Sci. 2024 Mar 15; 458:122925. PMID: 38340409.
      Citations:    Fields:    Translation:Humans
    16. Comella CL, Jankovic J, Hauser RA, Patel AT, Banach MD, Ehler E, Vitarella D, Rubio RG, Gross TM, ASPEN-1 Study Group. Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial. Neurology. 2024 02 27; 102(4):e208091. PMID: 38295339; PMCID: PMC10962918.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    17. Yuan L, Chen X, Jankovic J, Deng H. CADASIL: A NOTCH3-associated cerebral small vessel disease. J Adv Res. 2024 Jan 02. PMID: 38176524.
      Citations:    Fields:    
    18. Anandan C, Jankovic J. Botulinum toxin treatment in parkinsonism. J Neurol Sci. 2024 01 15; 456:122810. PMID: 38056063.
      Citations:    Fields:    Translation:Humans
    19. Junker J, Hall J, Berman BD, Vidailhet M, Roze E, B?umer T, Malaty IA, Shukla AW, Jankovic J, Reich SG, Espay AJ, Duque KR, Patel N, Perlmutter JS, Jinnah HA, Dystonia Coalition Study Group, Brandt V, Br?ggemann N. Longitudinal predictors of health-related quality of life in isolated dystonia. J Neurol. 2024 Feb; 271(2):852-863. PMID: 37839041; PMCID: PMC10827910.
      Citations:    Fields:    Translation:Humans
    20. Vollstedt EJ, Madoev H, Aasly A, Ahmad-Annuar A, Al-Mubarak B, Alcalay RN, Alvarez V, Amorin I, Annesi G, Arkadir D, Bardien S, Barker RA, Barkhuizen M, Basak AN, Bonifati V, Boon A, Brighina L, Brockmann K, Carmine Belin A, Carr J, Clarimon J, Cornejo-Olivas M, Correia Guedes L, Corvol JC, Crosiers D, Dam?sio J, Das P, de Carvalho Aguiar P, De Rosa A, Dorszewska J, Ertan S, Ferese R, Ferreira J, Gatto E, Gen? G, Giladi N, G?mez-Garre P, Hanagasi H, Hattori N, Hentati F, Hoffman-Zacharska D, Illarioshkin SN, Jankovic J, Jes?s S, Kaasinen V, Kievit A, Klivenyi P, Kostic V, Koziorowski D, K?hn AA, Lang AE, Lim SY, Lin CH, Lohmann K, Markovic V, Martikainen MH, Mellick G, Merello M, Milanowski L, Mir P, ?ztop-?akmak ?, Pimentel MMG, Pulkes T, Puschmann A, Rogaeva E, Sammler EM, Skaalum Petersen M, Skorvanek M, Spitz M, Suchowersky O, Tan AH, Termsarasab P, Thaler A, Tumas V, Valente EM, van de Warrenburg B, Williams-Gray CH, Wu RM, Zhang B, Zimprich A, Solle J, Padmanabhan S, Klein C. Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project. PLoS One. 2023; 18(10):e0292180. PMID: 37788254; PMCID: PMC10547150.
      Citations:    Fields:    Translation:Humans
    21. Li T, Le W, Jankovic J. Linking the cerebellum to Parkinson disease: an update. Nat Rev Neurol. 2023 11; 19(11):645-654. PMID: 37752351.
      Citations: 2     Fields:    Translation:Humans
    22. Jankovic J, Coffey B, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA, Stamler DA, Wieman M, Savola JM, Harary E, Alexander J, Barkay H, Gordon MF. Safety and Efficacy of Long-Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open-Label Extension Study. Mov Disord Clin Pract. 2023 Sep; 10(9):1388-1398. PMID: 37772282; PMCID: PMC10525047.
      Citations: 1     
    23. Cotton AC, Scorr L, McDonald W, Comella C, Perlmutter JS, Goetz CG, Jankovic J, Marsh L, Factor S, Jinnah HA. Assessing the Severity of Cervical Dystonia: Ask the Doctor or Ask the Patient? Mov Disord Clin Pract. 2023 Sep; 10(9):1399-1403. PMID: 37772296; PMCID: PMC10525044.
      Citations:    
    24. Terravecchia C, Mostile G, Chisari CG, Rascun? C, Terranova R, Cicero CE, Giuliano L, Donzuso G, Sciacca G, Luca A, Preux PM, Jankovic J, Zappia M, Nicoletti A. Retinal Thickness in Essential Tremor and Early Parkinson Disease: Exploring Diagnostic Insights. J Neuroophthalmol. 2024 Mar 01; 44(1):35-40. PMID: 37523235; PMCID: PMC10855993.
      Citations:    Fields:    Translation:Humans
    25. Jankovic J, Tsui J, Brin MF. Treatment of cervical dystonia with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine (Baltimore). 2023 Jul 01; 102(S1):e32403. PMID: 37499081; PMCID: PMC10374188.
      Citations:    Fields:    Translation:Humans
    26. Vanegas-Arroyave N, Jankovic J. Spinal cord stimulation for gait disturbances in Parkinson's disease. Expert Rev Neurother. 2023 Jul-Dec; 23(7):651-659. PMID: 37345383.
      Citations:    Fields:    Translation:Humans
    27. Makhoul K, Jankovic J. Real-world experience with VMAT2 inhibitors in Tourette syndrome. J Neurol. 2023 Sep; 270(9):4518-4522. PMID: 37301806.
      Citations: 1     Fields:    Translation:Humans
    28. Deng X, Yuan L, Jankovic J, Deng H. The role of the PLA2G6 gene in neurodegenerative diseases. Ageing Res Rev. 2023 08; 89:101957. PMID: 37236368.
      Citations:    Fields:    Translation:Humans
    29. Jankovic J, Carruthers J, Naumann M, Ogilvie P, Boodhoo T, Attar M, Gupta S, Singh R, Soliman J, Yushmanova I, Brin MF, Shen J. Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX?) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis. Toxins (Basel). 2023 05 17; 15(5). PMID: 37235376; PMCID: PMC10224273.
      Citations: 1     Fields:    Translation:Humans
    30. Baizabal-Carvallo JF, Alonso-Juarez M, Jankovic J. Contrasting features between Tourette syndrome and secondary tic disorders. J Neural Transm (Vienna). 2023 07; 130(7):931-936. PMID: 37117738; PMCID: PMC10144877.
      Citations:    Fields:    Translation:Humans
    31. Albanese A, Bhatia KP, Cardoso F, Comella C, Defazio G, Fung VSC, Hallett M, Jankovic J, Jinnah HA, Kaji R, Krauss JK, Lang A, Tan EK, Tijssen MAJ, Vidailhet M. Isolated Cervical Dystonia: Diagnosis and Classification. Mov Disord. 2023 08; 38(8):1367-1378. PMID: 36989390; PMCID: PMC10528915.
      Citations: 1     Fields:    Translation:Humans
    32. Lenka A, Jankovic J. Peripherally-induced Movement Disorders: An Update. Tremor Other Hyperkinet Mov (N Y). 2023; 13:8. PMID: 37008994; PMCID: PMC10064913.
      Citations:    Fields:    Translation:Humans
    33. Hull M, Parnes M, Jankovic J. Botulinum Neurotoxin Injections in Children with Self-Injurious Behaviors. Toxins (Basel). 2023 03 23; 15(4). PMID: 37104174; PMCID: PMC10141007.
      Citations:    Fields:    Translation:Humans
    34. Schneider SA, Desai S, Phokaewvarangkul O, Rosca EC, Sringean J, Anand P, Bravo G?, Cardoso F, Cervantes-Arslanian AM, Chovatiya H, Crosiers D, Dijkstra F, Fearon C, Grandas F, Guedj E, M?ndez-Guerrero A, Hassan M, Jankovic J, Lang AE, Makhoul K, Muccioli L, O'Shea SA, Ostovan VR, Perez-Sanchez JR, Ramdhani R, Ros-Castell? V, Schulte C, Shah P, Wojtecki L, Pal PK. COVID19-associated new-onset movement disorders: a follow-up study. J Neurol. 2023 May; 270(5):2409-2415. PMID: 36943516; PMCID: PMC10029788.
      Citations: 1     Fields:    Translation:Humans
    35. Baizabal-Carvallo JF, Jankovic J. The Clinical Characterization of Blocking Tics in Patients With Tourette Syndrome. J Mov Disord. 2023 May; 16(2):163-167. PMID: 36872859; PMCID: PMC10236012.
      Citations:    
    36. Lenka A, Jankovic J. How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson's disease? Expert Rev Neurother. 2023 02; 23(2):107-122. PMID: 36803618.
      Citations: 1     Fields:    Translation:Humans
    37. Makhoul K, Jankovic J. Driving Impairment in Movement Disorders. Mov Disord Clin Pract. 2023 Mar; 10(3):369-381. PMID: 36949799; PMCID: PMC10026316.
      Citations:    
    38. Baizabal-Carvallo JF, Alonso-Juarez M, Jankovic J. Oromandibular tics associated with Tourette syndrome. J Neurol. 2023 May; 270(5):2591-2596. PMID: 36723683.
      Citations: 2     Fields:    Translation:Humans
    39. Baizabal-Carvallo JF, Jankovic J. Secondary dystonia following parenchymal brain tumors. J Neurol Sci. 2023 03 15; 446:120577. PMID: 36738494.
      Citations:    Fields:    Translation:Humans
    40. Vollstedt EJ, Schaake S, Lohmann K, Padmanabhan S, Brice A, Lesage S, Tesson C, Vidailhet M, Wurster I, Hentati F, Mirelman A, Giladi N, Marder K, Waters C, Fahn S, Kasten M, Br?ggemann N, Borsche M, Foroud T, Tolosa E, Garrido A, Annesi G, Gagliardi M, Bozi M, Stefanis L, Ferreira JJ, Correia Guedes L, Avenali M, Petrucci S, Clark L, Fedotova EY, Abramycheva NY, Alvarez V, Men?ndez-Gonz?lez M, Jes?s Maestre S, G?mez-Garre P, Mir P, Belin AC, Ran C, Lin CH, Kuo MC, Crosiers D, Wszolek ZK, Ross OA, Jankovic J, Nishioka K, Funayama M, Clarimon J, Williams-Gray CH, Camacho M, Cornejo-Olivas M, Torres-Ramirez L, Wu YR, Lee-Chen GJ, Morgadinho A, Pulkes T, Termsarasab P, Berg D, Kuhlenb?umer G, K?hn AA, Borngr?ber F, de Michele G, De Rosa A, Zimprich A, Puschmann A, Mellick GD, Dorszewska J, Carr J, Ferese R, Satake W, Toda T, Rossi M, Merello M, Lynch T, Olszewska DA, Lim SY, Ahmad-Annuar A, Tan AH, Al-Mubarak B, Hanagasi H, Koziorowski D, Ertan S, Gen? G, de Carvalho Aguiar P, Barkhuizen M, Pimentel MMG, Saunders-Pullman R, van de Warrenburg B, Bressman S, Toft M, Appel-Cresswell S, Lang AE, Skorvanek M, Boon AJW, Kr?ger R, Sammler EM, Tumas V, Zhang BR, Garraux G, Chung SJ, Kim YJ, Winkelmann J, Sue CM, Tan EK, Dam?sio J, Kliv?nyi P, Kostic VS, Arkadir D, Martikainen M, Borges V, Hertz JM, Brighina L, Spitz M, Suchowersky O, Riess O, Das P, Mollenhauer B, Gatto EM, Petersen MS, Hattori N, Wu RM, Illarioshkin SN, Valente EM, Aasly JO, Aasly A, Alcalay RN, Thaler A, Farrer MJ, Brockmann K, Corvol JC, Klein C, MJFF Global Genetic Parkinson's Disease Study Group, Gambardella S, Chase B, Markopoulou K. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort. Mov Disord. 2023 02; 38(2):286-303. PMID: 36692014.
      Citations: 2     Fields:    Translation:Humans
    41. Defazio G, Gigante AF, Hallett M, Berardelli A, Perlmutter JS, Berman BD, Jankovic J, B?umer T, Comella C, Ercoli T, Ferrazzano G, Fox SH, Kim HJ, Moukheiber ES, Richardson SP, Weissbach A, Jinnah HA. Motor and psychiatric features in idiopathic blepharospasm: A data-driven cluster analysis. Parkinsonism Relat Disord. 2022 11; 104:94-98. PMID: 36306537; PMCID: PMC11187571.
      Citations:    Fields:    Translation:Humans
    42. Lu S, Ma M, Mao X, Bacino CA, Jankovic J, Sutton VR, Bartley JA, Wang X, Rosenfeld JA, Beleza-Meireles A, Chauhan J, Pan X, Li M, Liu P, Prescott K, Amin S, Davies G, Wangler MF, Dai Y, Bellen HJ. De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movement. Am J Hum Genet. 2022 10 06; 109(10):1932-1943. PMID: 36206744; PMCID: PMC9606480.
      Citations: 4     Fields:    Translation:HumansAnimals
    43. Clark LN, Gao Y, Wang GT, Hernandez N, Ashley-Koch A, Jankovic J, Ottman R, Leal SM, Rodriguez SMB, Louis ED. Whole genome sequencing identifies candidate genes for familial essential tremor and reveals biological pathways implicated in essential tremor aetiology. EBioMedicine. 2022 Nov; 85:104290. PMID: 36183486; PMCID: PMC9525816.
      Citations:    Fields:    Translation:Humans
    44. Vu JP, Cisneros E, Zhao J, Lee HY, Jankovic J, Factor SA, Goetz CG, Barbano RL, Perlmutter JS, Jinnah HA, Richardson SP, Stebbins GT, Elble RJ, Comella CL, Peterson DA. From null to midline: changes in head posture do not predictably change head tremor in cervical dystonia. Dystonia. 2022; 1. PMID: 37101941; PMCID: PMC10128866.
      Citations: 1     
    45. Defazio G, Hallett M, Berardelli A, Perlmutter JS, Berman BD, Jankovic J, B?umer T, Comella C, Ercoli T, Ferrazzano G, Fox SH, Kim HJ, Moukheiber ES, Pirio Richardson S, Weissbach A, Gigante AF, Jinnah HA. Measurement Properties of Clinical Scales Rating the Severity of Blepharospasm: A Multicenter Observational Study. Mov Disord Clin Pract. 2022 Oct; 9(7):949-955. PMID: 36247913; PMCID: PMC9547140.
      Citations: 1     
    46. Gadot R, Vanegas Arroyave N, Dang H, Anand A, Najera RA, Taneff LY, Bellows S, Tarakad A, Jankovic J, Horn A, Shofty B, Viswanathan A, Sheth SA. Association of clinical outcomes and connectivity in awake versus asleep deep brain stimulation for Parkinson disease. J Neurosurg. 2023 04 01; 138(4):1016-1027. PMID: 35932263; PMCID: PMC10215008.
      Citations:    
    47. Lenka A, Di Maria G, Lamotte G, Bahroo L, Jankovic J. Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson's disease. Expert Rev Neurother. 2022 06; 22(6):489-498. PMID: 35710101.
      Citations:    Fields:    Translation:Humans
    48. Hill EJ, Robak LA, Al-Ouran R, Deger J, Fong JC, Vandeventer PJ, Schulman E, Rao S, Saade H, Savitt JM, von Coelln R, Desai N, Doddapaneni H, Salvi S, Dugan-Perez S, Muzny DM, McGuire AL, Liu Z, Gibbs RA, Shaw C, Jankovic J, Shulman LM, Shulman JM. Genome Sequencing in the Parkinson Disease Clinic. Neurol Genet. 2022 Aug; 8(4):e200002. PMID: 35747619; PMCID: PMC9210549.
      Citations:    
    49. Scorr LM, Cho HJ, Kilic-Berkmen G, McKay JL, Hallett M, Klein C, Baumer T, Berman BD, Feuerstein JS, Perlmutter JS, Berardelli A, Ferrazzano G, Wagle-Shukla A, Malaty IA, Jankovic J, Bellows ST, Barbano RL, Vidailhet M, Roze E, Bonnet C, Mahajan A, LeDoux MS, Fung VSC, Chang FCF, Defazio G, Ercoli T, Factor S, Wojno T, Jinnah HA. Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review. Dystonia. 2022; 1. PMID: 36248010; PMCID: PMC9557246.
      Citations: 2     
    50. Jankovic J, Baizabal-Carvallo JF, Alonso-Juarez M. Dystonic motor and phonic tics in Tourette syndrome. J Neurol. 2022 Oct; 269(10):5312-5318. PMID: 35567613.
      Citations:    Fields:    
    51. Du W, Bain PG, Defazio G, Jankovic J, Kim CY, Tan EK, Louis ED, Vidailhet M. The Conundrum of Dystonia in Essential Tremor Patients: How does One Classify these Cases? Tremor Other Hyperkinet Mov (N Y). 2022; 12:15. PMID: 35646424; PMCID: PMC9104429.
      Citations:    Fields:    Translation:Humans
    52. Jankovic J, Baizabal-Carvallo JF. The clinical phenomenology and correlations of oculogyric tics. Acta Neurol Belg. 2022 Aug; 122(4):925-930. PMID: 35397742.
      Citations: 1     Fields:    Translation:Humans
    53. Zhang Z, Cisneros E, Lee HY, Vu JP, Chen Q, Benadof CN, Whitehill J, Rouzbehani R, Sy DT, Huang JS, Sejnowski TJ, Jankovic J, Factor S, Goetz CG, Barbano RL, Perlmutter JS, Jinnah HA, Berman BD, Richardson SP, Stebbins GT, Comella CL, Peterson DA. Hold that pose: capturing cervical dystonia's head deviation severity from video. Ann Clin Transl Neurol. 2022 05; 9(5):684-694. PMID: 35333449; PMCID: PMC9082391.
      Citations:    Fields:    Translation:Humans
    54. Vijayakumar D, Jankovic J. Slowing Parkinson's Disease Progression with Vaccination and Other Immunotherapies. CNS Drugs. 2022 04; 36(4):327-343. PMID: 35212935.
      Citations:    Fields:    Translation:HumansPHPublic Health
    55. Jankovic J, Baizabal-Carvallo JF. Sex differences in patients with Tourette syndrome. CNS Spectr. 2022 Feb 16; 1-7. PMID: 35170423.
      Citations: 1     Fields:    
    56. Liao C, Castonguay CE, Heilbron K, Vuokila V, Medeiros M, Houle G, Ross JP, Catoire H, Kang J, Mueller SH, Hopfner F, Clark LN, Soto-Beasley AI, Hallett M, Wszolek ZK, Pendziwiat M, Lorenzo-Betancor O, Seppi K, Berg D, Postuma RB, Jankovic J, Testa CM, Ross OA, Arzberger T, Louis ED, Mandich P, Vitale C, Barone P, Alonso-Navarro H, Rajput A, Dion PA, Rouleau GA, 23andMe Research Team, Ak?imen F, Diez-Fairen M, Girard SL, Lorenz D, Klebe S, Vilari?o-G?ell C, Bernard G, Dupr? N, Chouinard S, Garc?a-Mart?n E, Ag?ndez JAG, Jim?nez-Jim?nez FJ, Pastor P, Deuschl G, Kuhlenba?mer G, Meijer IA. Association of Essential Tremor With Novel Risk Loci: A Genome-Wide Association Study and Meta-analysis. JAMA Neurol. 2022 02 01; 79(2):185-193. PMID: 34982113; PMCID: PMC8728658.
      Citations: 1     Fields:    Translation:HumansCells
    57. Vu JP, Cisneros E, Lee HY, Le L, Chen Q, Guo XA, Rouzbehani R, Jankovic J, Factor S, Goetz CG, Barbano RL, Perlmutter JS, Jinnah HA, Pirio Richardson S, Stebbins GT, Elble R, Comella CL, Peterson DA. Head tremor in cervical dystonia: Quantifying severity with computer vision. J Neurol Sci. 2022 Mar 15; 434:120154. PMID: 35101766; PMCID: PMC9059761.
      Citations: 1     Fields:    Translation:Humans
    58. Zhou ZD, Jankovic J, Ashizawa T, Tan EK. Neurodegenerative diseases associated with non-coding CGG tandem repeat expansions. Nat Rev Neurol. 2022 03; 18(3):145-157. PMID: 35022573.
      Citations: 1     Fields:    Translation:HumansCells
    59. Lenka A, Jankovic J. Sports-Related Dystonia. Tremor Other Hyperkinet Mov (N Y). 2021; 11:54. PMID: 35036047; PMCID: PMC8698216.
      Citations:    Fields:    Translation:Humans
    60. Kilic-Berkmen G, Pirio Richardson S, Perlmutter JS, Hallett M, Klein C, Wagle-Shukla A, Malaty IA, Reich SG, Berman BD, Feuerstein J, Jankovic J, Mahajan A, Espay AJ, Barbano RL, LeDoux MS, Pantelyat A, Frank S, Stover N, Berardelli A, Leegwater-Kim J, Defazio G, Norris SA, Jinnah HA, Dystonia Coalition Investigators, Vidailhet M, Roze E. Current Guidelines for Classifying and Diagnosing Cervical Dystonia: Empirical Evidence and Recommendations. Mov Disord Clin Pract. 2022 Feb; 9(2):183-190. PMID: 35146058; PMCID: PMC8810420.
      Citations: 2     
    61. Welton T, Cardoso F, Carr JA, Chan LL, Jankovic J, Tan EK, Deuschl G. Essential tremor. Nat Rev Dis Primers. 2021 11 11; 7(1):83. PMID: 34764294.
      Citations: 2     Fields:    Translation:HumansAnimals
    62. Hull M, Parnes M, Jankovic J. Increased Incidence of Functional (Psychogenic) Movement Disorders in Children and Adults Amid the COVID-19 Pandemic: A Cross-sectional Study. Neurol Clin Pract. 2021 Oct; 11(5):e686-e690. PMID: 34840884; PMCID: PMC8610548.
      Citations: 14     
    63. Bologna M, Truong D, Jankovic J. The etiopathogenetic and pathophysiological spectrum of parkinsonism. J Neurol Sci. 2022 Feb 15; 433:120012. PMID: 34642022.
      Citations: 1     Fields:    Translation:Humans
    64. Bellows S, Jankovic J. Parkinsonism and tremor syndromes. J Neurol Sci. 2022 Feb 15; 433:120018. PMID: 34686357.
      Citations: 3     Fields:    Translation:Humans
    65. Coffey B, Jankovic J, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA, Stamler DA, Wieman M, Savola JM, Gordon MF, Alexander JK, Barkay H, Harary E. Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial. JAMA Netw Open. 2021 10 01; 4(10):e2129397. PMID: 34661664; PMCID: PMC8524312.
      Citations:    Fields:    Translation:Humans
    66. Jankovic J, Coffey B, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA, Stamler DA, Wieman M, Savola JM, Gordon MF, Alexander J, Barkay H, Harary E. Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial. JAMA Netw Open. 2021 10 01; 4(10):e2128204. PMID: 34609495; PMCID: PMC8493441.
      Citations: 1     Fields:    Translation:Humans
    67. Jankovic J, Truong DD, Bologna M. Editorial "Parkinsonism across the spectrum of movement disorders and beyond". J Neurol Sci. 2022 Feb 15; 433:120013. PMID: 34625287.
      Citations:    Fields:    Translation:Humans
    68. Jankovic J, Baizabal-Carvallo JF, Alonso-Juarez M. Self-injurious behavior in Tourette syndrome. J Neurol. 2022 May; 269(5):2453-2459. PMID: 34596744.
      Citations:    Fields:    Translation:Humans
    69. Billnitzer A, Jankovic J. The Clinical Value of Patient Home Videos in Movement Disorders. Tremor Other Hyperkinet Mov (N Y). 2021; 11:37. PMID: 34692230; PMCID: PMC8485864.
      Citations:    Fields:    Translation:Humans
    70. Scorr LM, Factor SA, Parra SP, Kaye R, Paniello RC, Norris SA, Perlmutter JS, Berman BD, Mailly M, Jankovic J, LeDoux MS, Barbano R, Chang FCF, Fung VSC, Pirio Richardson S, Blitzer A, Jinnah HA, B?umer T, Usnich T, Roze E, Vidailhet M. Oromandibular Dystonia: A Clinical Examination of 2,020 Cases. Front Neurol. 2021; 12:700714. PMID: 34603182; PMCID: PMC8481678.
      Citations: 1     
    71. Defazio G, Jinnah HA, Berardelli A, Perlmutter JS, Berkmen GK, Berman BD, Jankovic J, Comella C, Cotton AC, Ercoli T, Ferrazzano G, Fox S, Kim HJ, Moukheiber ES, Richardson SP, Weissbach A, Wrigth LJ, Hallett M, B?umer T. Diagnostic criteria for blepharospasm: A multicenter international study. Parkinsonism Relat Disord. 2021 10; 91:109-114. PMID: 34583301; PMCID: PMC9048224.
      Citations:    Fields:    Translation:Humans
    72. Mitsikostas DD, Dekundy A, Hanschmann A, Althaus M, Scheschonka A, Pagan F, Jankovic J. Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-na?ve subjects. Curr Med Res Opin. 2021 10; 37(10):1761-1768. PMID: 34384301.
      Citations:    Fields:    Translation:Humans
    73. Hafeez MU, Moore M, Hafeez K, Jankovic J. Exploring the role of botulinum toxin in critical care. Expert Rev Neurother. 2021 08; 21(8):881-894. PMID: 34281468.
      Citations: 1     Fields:    Translation:HumansCells
    74. Wang M, Sajobi T, Morgante F, Adler C, Agarwal P, Berardelli A, Berman BD, Blumin J, Brashear A, Deik A, Duque K, Espay AJ, Ferrazzano G, Feuerstein J, Fox S, Frank S, Hallett M, Jankovic J, LeDoux MS, Leegwater-Kim J, Mahajan A, Malaty IA, Ondo W, Pantelyat A, Pirio-Richardson S, Saunders-Pullman R, Suchowersky O, Truong D, Shukla AW, Perlmutter JS, Jinnah HA, Martino D, B?umer T, Borsche M, Roze E, Vidailhet M. Predictive modeling of spread in adult-onset isolated dystonia: Key properties and effect of tremor inclusion. Eur J Neurol. 2021 12; 28(12):3999-4009. PMID: 34296504; PMCID: PMC9100858.
      Citations:    Fields:    Translation:Humans
    75. Hill EJ, Jankovic J. Antiglutamic Acid Decarboxylase 65 Antibody-Associated Hemiataxia. Neurol Clin Pract. 2021 Aug; 11(4):e564-e566. PMID: 34484960; PMCID: PMC8382435.
      Citations:    
    76. Sun YV, Li C, Hui Q, Huang Y, Barbano R, Rodriguez R, Malaty IA, Reich S, Bambarger K, Holmes K, Jankovic J, Patel NJ, Berman BD, LeDoux MS, Espay AJ, Agarwal P, Pirio-Richardson S, Frank SA, Ondo WG, Saunders-Pullman R, Natividad S, Berardelli A, Pantelyat AY, Brashear A, Fox SH, Zittel S, Maurer A, Gelderblom M, Cruchaga C, Cotton AC, Kilic-Berkmen G, Freeman A, Factor SA, Scorr L, Bremner JD, Vaccarino V, Quyyumi AA, Perlmutter JS, Jinnah HA, Roze E, Vidailhet M, Chouinard S, Kasten M, Kr?mer UM, Neis M, B?umer T, Loens S, Borsche M, Volkmann J, Odorfer T, K?hn AA, Borngr?ber F, K?nig IR, Klein C, Lohmann K. A Multi-center Genome-wide Association Study of Cervical Dystonia. Mov Disord. 2021 12; 36(12):2795-2801. PMID: 34320236; PMCID: PMC8688173.
      Citations: 1     Fields:    Translation:Humans
    77. Lenka A, Jankovic J. Tremor Syndromes: An Updated Review. Front Neurol. 2021; 12:684835. PMID: 34381412; PMCID: PMC8350038.
      Citations: 1     
    78. Jankovic J, Baizabal-Carvallo JF. Beyond tics: movement disorders in patients with Tourette syndrome. J Neural Transm (Vienna). 2021 08; 128(8):1177-1183. PMID: 34302221.
      Citations:    Fields:    Translation:Humans
    79. Marsili L, Bologna M, Jankovic J, Colosimo C. Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal. Expert Opin Drug Saf. 2021 Jun; 20(6):695-705. PMID: 33831328.
      Citations: 1     Fields:    Translation:Humans
    80. Cisneros E, Vu JP, Lee HY, Chen Q, Benadof CN, Zhang Z, Pettitt EA, Joshi SK, Barbano RL, Jankovic J, Jinnah HA, Perlmutter JS, Berman BD, Mahajan A, Goetz CG, Stebbins GT, Comella CL, Peterson DA. Does Raising the Arms Modify Head Tremor Severity in Cervical Dystonia? Tremor Other Hyperkinet Mov (N Y). 2021 06 23; 11:21. PMID: 34221696; PMCID: PMC8231450.
      Citations:    Fields:    Translation:Humans
    81. Mostile G, Terranova R, Terravecchia C, Cicero CE, Giuliano L, Chisari C, Luca A, Preux PM, Jankovic J, Zappia M, Nicoletti A, Rascun? C, Dav? M. Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approach. Parkinsonism Relat Disord. 2021 06; 87:124-129. PMID: 34030068.
      Citations: 4     Fields:    Translation:Humans
    82. Makhoul K, Jankovic J. Tourette Syndrome and Driving. Mov Disord Clin Pract. 2021 Jul; 8(5):763-768. PMID: 34307750; PMCID: PMC8287170.
      Citations:    
    83. Litvan I, Proudfoot JA, Martin ER, Standaert D, Riley D, Hall D, Marras C, Bayram E, Dubinsky RM, Bordelon Y, Reich S, Shprecher D, Kluger B, Cunningham C, Schellenberg GD, Jankovic J. Gene-Environment Interactions in Progressive Supranuclear Palsy. Front Neurol. 2021; 12:664796. PMID: 33897612; PMCID: PMC8062875.
      Citations:    
    84. Gatto EM, Walker RH, Gonzalez C, Cesarini M, Cossu G, Stephen CD, Balint B, Jankovic J, Morgante F, Jinnah HA, Rare Movement Disorders Study Group of the International Parkinson Disease, Movement Disorders Socie, Rodr?guez-Violante M. Worldwide barriers to genetic testing for movement disorders. Eur J Neurol. 2021 06; 28(6):1901-1909. PMID: 33730413.
      Citations: 1     Fields:    Translation:Humans
    85. Billnitzer A, Jankovic J. Pilot Study to Evaluate Pimavanserin for the Treatment of Motor and Behavioral Symptoms of Tourette Syndrome. Mov Disord Clin Pract. 2021 Jul; 8(5):694-700. PMID: 34307741; PMCID: PMC8287163.
      Citations:    
    86. Bellows ST, Jankovic J. Phenotypic Features of Isolated Essential Tremor, Essential Tremor Plus, and Essential Tremor-Parkinson's Disease in a Movement Disorders Clinic. Tremor Other Hyperkinet Mov (N Y). 2021 03 29; 11:12. PMID: 33828900; PMCID: PMC8015706.
      Citations: 6     Fields:    Translation:Humans
    87. Hull M, Parnes M, Jankovic J. Botulinum Neurotoxin Injections in Childhood Opisthotonus. Toxins (Basel). 2021 02 12; 13(2). PMID: 33673369; PMCID: PMC7918608.
      Citations:    Fields:    Translation:Humans
    88. Hill EJ, Mangleburg CG, Alfradique-Dunham I, Ripperger B, Stillwell A, Saade H, Rao S, Fagbongbe O, von Coelln R, Tarakad A, Hunter C, Dawe RJ, Jankovic J, Shulman LM, Buchman AS, Shulman JM. Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity. Parkinsonism Relat Disord. 2021 03; 84:105-111. PMID: 33607526; PMCID: PMC7987213.
      Citations: 2     Fields:    Translation:Humans
    89. Zhang JF, Wang XX, Feng Y, Fekete R, Jankovic J, Wu YC. Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies. Front Psychiatry. 2021; 12:635494. PMID: 33633615; PMCID: PMC7900512.
      Citations: 2     
    90. Junker J, Berman BD, Hall J, Wahba DW, Brandt V, Perlmutter JS, Jankovic J, Malaty IA, Wagle Shukla A, Reich SG, Espay AJ, Duque KR, Patel N, Roze E, Vidailhet M, Jinnah HA, Br?ggemann N. Quality of life in isolated dystonia: non-motor manifestations matter. J Neurol Neurosurg Psychiatry. 2021 Feb 09. PMID: 33563813; PMCID: PMC8356023.
      Citations: 4     Fields:    
    91. Alfradique-Dunham I, Al-Ouran R, von Coelln R, Blauwendraat C, Hill E, Luo L, Stillwell A, Young E, Kaw A, Tan M, Liao C, Hernandez D, Pihlstrom L, Grosset D, Shulman LM, Liu Z, Rouleau GA, Nalls M, Singleton AB, Morris H, Jankovic J, Shulman JM. Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor Subtypes. Neurol Genet. 2021 Apr; 7(2):e557. PMID: 33987465; PMCID: PMC8112852.
      Citations: 3     
    92. Makhoul K, Jankovic J. Parkinson's disease after COVID-19. J Neurol Sci. 2021 03 15; 422:117331. PMID: 33540185; PMCID: PMC9755718.
      Citations: 11     Fields:    Translation:Humans
    93. Tsetsos F, Yu D, Sul JH, Huang AY, Illmann C, Osiecki L, Darrow SM, Hirschtritt ME, Greenberg E, Muller-Vahl KR, Stuhrmann M, Dion Y, Rouleau GA, Aschauer H, Stamenkovic M, Sandor P, Barr CL, Grados MA, Singer HS, Hebebrand J, Hinney A, King RA, Fernandez TV, Barta C, Tarnok Z, Nagy P, Depienne C, Budman CL, Rizzo R, Lyon GJ, McMahon WM, Batterson JR, Cath DC, Malaty IA, Okun MS, Berlin C, Woods DW, Lee PC, Jankovic J, Robertson MM, Gilbert DL, Brown LW, Coffey BJ, Dietrich A, Hoekstra PJ, Kuperman S, Zinner SH, Wagner M, Knowles JA, Jeremy Willsey A, Tischfield JA, Heiman GA, Cox NJ, Freimer NB, Neale BM, Davis LK, Coppola G, Mathews CA, Scharf JM, Paschou P, Tourette Association of America International Consortium for Genetics, Coppola G, Darrow S, Davis LK, Dion Y, Freimer NB, Greenberg E, Kurlan R, Leckman JF, Lyon GJ, Malaty IA, Neale BM, Okun MS, Rouleau GA, Smit JH, Gilles de la Tourette GWAS Replication Initiative, Aschauer HAH, Barta C, Depienne C, Konstantinidis A, Paschou P, Tsetsos F, Wolanczyk T, Tourette International Collaborative Genetics Study, Brown L, Cheon KA, Fernandez TV, Garcia-Delgar B, Gilbert D, Grice DE, Hedderly T, Heiman GA, Heyman I, Huyser C, Kim YK, Kim YS, Koh YJ, Kook S, Leventhal BL, Plessen KJ, Roessner V, Shin EY, Song DH, Song J, Willsey AJ, Zinner S, Psychiatric Genomics Consortium Tourette Syndrome Working Group, Aschauer H, Fernandez T, Heiman G, Hoekstra P, Tischfield J, Woods D, Schl?gelhofer M, N?then MM, Worbe Y, Hartmann A, M?ller-Vahl K, Hagstr?m J, Madruga-Garrido M, Mir P, Morer A, M?nchau A. Synaptic processes and immune-related pathways implicated in Tourette syndrome. Transl Psychiatry. 2021 01 18; 11(1):56. PMID: 33462189; PMCID: PMC7814139.
      Citations: 6     Fields:    Translation:HumansCells
    94. Vu JP, Lee HY, Chen Q, Cisneros E, Barbano RL, Goetz CG, Jankovic J, Jinnah HA, Perlmutter JS, Berman BD, Appelbaum MI, Stebbins GT, Comella CL, Peterson DA. Head tremor and pain in cervical dystonia. J Neurol. 2021 May; 268(5):1945-1950. PMID: 33417005; PMCID: PMC8076053.
      Citations: 5     Fields:    Translation:Humans
    95. Anandan C, Jankovic J. Botulinum Toxin in Movement Disorders: An Update. Toxins (Basel). 2021 Jan 08; 13(1). PMID: 33430071; PMCID: PMC7827923.
      Citations: 12     Fields:    Translation:Humans
    96. Niemann N, Billnitzer A, Jankovic J. Parkinson's disease and skin. Parkinsonism Relat Disord. 2021 01; 82:61-76. PMID: 33248395.
      Citations: 8     Fields:    Translation:Humans
    97. Tarakad A, Jankovic J. Recent advances in understanding and treatment of Parkinson's disease. Fac Rev. 2020; 9:6. PMID: 33659938; PMCID: PMC7886054.
      Citations: 4     
    98. Kordower JH, Okun MS, Jankovic J. Reply to: "Toward a Personalized Approach to Parkinson's Cell Therapy". Mov Disord. 2020 11; 35(11):2120-2121. PMID: 33463751.
      Citations:    Fields:    Translation:HumansCells
    99. Cisneros E, Stebbins GT, Chen Q, Vu JP, Benadof CN, Zhang Z, Barbano RL, Fox SH, Goetz CG, Jankovic J, Jinnah HA, Perlmutter JS, Adler CH, Factor SA, Reich SG, Rodriguez R, Severt LL, Stover NP, Berman BD, Comella CL, Peterson DA. It's tricky: Rating alleviating maneuvers in cervical dystonia. J Neurol Sci. 2020 Dec 15; 419:117205. PMID: 33160248; PMCID: PMC7728456.
      Citations: 3     Fields:    Translation:Humans
    100. Shaikh AG, Beylergil SB, Scorr L, Kilic-Berkmen G, Freeman A, Klein C, Junker J, Loens S, Br?ggemann N, M?nchau A, B?umer T, Vidailhet M, Roze E, Bonnet C, Jankovic J, Jimenez-Shahed J, Patel N, Marsh L, Comella C, Barbano RL, Berman BD, Malaty I, Wagle Shukla A, Reich SG, Ledoux MS, Berardelli A, Ferrazzano G, Stover N, Ondo W, Pirio Richardson S, Saunders-Pullman R, Mari Z, Agarwal P, Adler C, Chouinard S, Fox SH, Brashear A, Truong D, Suchowersky O, Frank S, Factor S, Perlmutter J, Jinnah HA. Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition Cohort. Neurology. 2021 01 26; 96(4):e563-e574. PMID: 33046615; PMCID: PMC7905789.
      Citations: 16     Fields:    Translation:Humans
    101. Billnitzer A, Jankovic J. Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments. Neurotherapeutics. 2020 10; 17(4):1681-1693. PMID: 32856174; PMCID: PMC7851278.
      Citations: 15     Fields:    Translation:Humans
    102. York MK, Benge JF, Hunter C, Jankovic J. A validation of a self-administered screening test for Parkinson's disease. J Neurol Sci. 2020 Nov 15; 418:117116. PMID: 32919368.
      Citations:    Fields:    Translation:Humans
    103. Norris SA, Jinnah HA, Klein C, Jankovic J, Berman BD, Mahajan A, Espay AJ, Murthy AV, Fung VSC, LeDoux MS, Chang FCF, Vidailhet M, Testa C, Barbano R, Malaty IA, Loens S, Wright LJ, Perlmutter JS, Roze E, B?umer T. Clinical and Demographic Characteristics of Upper Limb Dystonia. Mov Disord. 2020 11; 35(11):2086-2090. PMID: 32845549; PMCID: PMC8350751.
      Citations: 1     Fields:    Translation:Humans
    104. Robak LA, Du R, Yuan B, Gu S, Alfradique-Dunham I, Kondapalli V, Hinojosa E, Stillwell A, Young E, Zhang C, Song X, Du H, Gambin T, Jhangiani SN, Coban Akdemir Z, Muzny DM, Tejomurtula A, Ross OA, Shaw C, Jankovic J, Bi W, Posey JE, Lupski JR, Shulman JM. Integrated sequencing and array comparative genomic hybridization in familial Parkinson disease. Neurol Genet. 2020 Oct; 6(5):e498. PMID: 32802956; PMCID: PMC7413630.
      Citations: 4     
    105. Rezvanian S, Litvan I, Standaert D, Jankovic J, Reich SG, Hall D, Shprecher DR, Bordelon Y, Dubinsky R, Kluger B. Understanding the relationship between freezing of gait and other progressive supranuclear palsy features. Parkinsonism Relat Disord. 2020 09; 78:56-60. PMID: 32731191.
      Citations: 4     Fields:    Translation:Humans
    106. Jankovic J, Okun MS, Kordower JH. Stem Cells: Scientific and Ethical Quandaries of a Personalized Approach to Parkinson's Disease. Mov Disord. 2020 08; 35(8):1312-1314. PMID: 32529662.
      Citations: 6     Fields:    Translation:HumansCells
    107. Bhidayasiri R, Kane JM, Frei KP, Caroff SN, Fahn S, Jankovic J, Hauser RA, Truong DD, Correll CU. Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool. Parkinsonism Relat Disord. 2020 08; 77:141-145. PMID: 32823151.
      Citations:    Fields:    Translation:Humans
    108. Jankovic J, Tan EK. Parkinson's disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry. 2020 08; 91(8):795-808. PMID: 32576618.
      Citations: 66     Fields:    Translation:Humans
    109. Jankovic J. Treatment of Movement Disorders. Neurol Clin. 2020 05; 38(2):xiii-xiv. PMID: 32279722.
      Citations:    Fields:    
    110. Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J. Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol. 2020 06; 16(6):303-318. PMID: 32332985.
      Citations: 65     Fields:    Translation:HumansAnimals
    111. Jankovic J, Baizabal-Carvallo JF. Reply to Gender Differences in Functional Movement Disorders: Sociocultural or Biological? Mov Disord Clin Pract. 2020 May; 7(4):480-481. PMID: 32373674; PMCID: PMC7197323.
      Citations:    
    112. Pick S, Anderson DG, Asadi-Pooya AA, Aybek S, Baslet G, Bloem BR, Bradley-Westguard A, Brown RJ, Carson AJ, Chalder T, Damianova M, David AS, Edwards MJ, Epstein SA, Espay AJ, Goldstein LH, Hallett M, Jankovic J, Joyce EM, Kanaan RA, Keynejad RC, Kozlowska K, LaFaver K, LaFrance WC, Lang AE, Lehn A, Lidstone S, Maurer CW, Mildon B, Morgante F, Myers L, Nicholson C, Nielsen G, Perez DL, Popkirov S, Reuber M, Rommelfanger KS, Schwingenshuh P, Serranova T, Shotbolt P, Stebbins GT, Stone J, Tijssen MA, Tinazzi M, Nicholson TR, Garcin B. Outcome measurement in functional neurological disorder: a systematic review and recommendations. J Neurol Neurosurg Psychiatry. 2020 06; 91(6):638-649. PMID: 32111637; PMCID: PMC7279198.
      Citations: 19     Fields:    Translation:Humans
    113. Bashir HH, Jankovic J. Treatment of Tardive Dyskinesia. Neurol Clin. 2020 05; 38(2):379-396. PMID: 32279716.
      Citations: 3     Fields:    Translation:Humans
    114. Bellows S, Jankovic J. Reply to Comment on Re-Visiting Immunogenicity Associated with Botulinum Toxin Treatment. Toxins 2019, 11, 491. Toxins (Basel). 2020 01 23; 12(2). PMID: 31979241; PMCID: PMC7076880.
      Citations: 1     Fields:    
    115. Chen Q, Vu JP, Cisneros E, Benadof CN, Zhang Z, Barbano RL, Goetz CG, Jankovic J, Jinnah HA, Perlmutter JS, Appelbaum MI, Stebbins GT, Comella CL, Peterson DA. Postural Directionality and Head Tremor in Cervical Dystonia. Tremor Other Hyperkinet Mov (N Y). 2020; 10. PMID: 32015932; PMCID: PMC6988138.
      Citations: 6     Fields:    Translation:Humans
    116. Jankovic J. Treatment of tics associated with Tourette syndrome. J Neural Transm (Vienna). 2020 05; 127(5):843-850. PMID: 31955299.
      Citations: 6     Fields:    Translation:Humans
    117. Blauwendraat C, Reed X, Krohn L, Heilbron K, Bandres-Ciga S, Tan M, Gibbs JR, Hernandez DG, Kumaran R, Langston R, Bonet-Ponce L, Alcalay RN, Hassin-Baer S, Greenbaum L, Iwaki H, Leonard HL, Grenn FP, Ruskey JA, Sabir M, Ahmed S, Makarious MB, Toft M, van Hilten JJ, Marinus J, Sharma M, Siitonen A, Majamaa K, Eerola-Rautio J, Tienari PJ, 23andMe Research Team, Pantelyat A, Hillis AE, Dawson TM, Rosenthal LS, Albert MS, Resnick SM, Ferrucci L, Morris CM, Pletnikova O, Troncoso J, Grosset D, Noyce AJ, Masliah E, Wood N, Hardy J, Shulman LM, Jankovic J, Shulman JM, Cannon P, Scholz SW, Morris H, Cookson MR, Nalls MA, Gan-Or Z, Singleton AB, Pihlstr?m L, Schulte C, Brockmann K, Lesage S, Corvol JC, Brice A, Heutink P, Gasser T. Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia. Brain. 2020 01 01; 143(1):234-248. PMID: 31755958; PMCID: PMC6935749.
      Citations: 55     Fields:    Translation:HumansCells
    118. Tanner CM, Pahwa R, Hauser RA, Oertel WH, Isaacson SH, Jankovic J, Johnson R, Chernick D, Hubble J. EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's Disease. J Parkinsons Dis. 2020; 10(2):543-558. PMID: 31929122; PMCID: PMC7242830.
      Citations: 6     Fields:    Translation:Humans
    119. Jankovic J, Baizabal-Carvallo JF. Gender Differences in Functional Movement Disorders. Mov Disord Clin Pract. 2020 Feb; 7(2):182-187. PMID: 32071937; PMCID: PMC7011817.
      Citations: 12     
    120. Alonso-Juarez M, Jankovic J, Baizabal-Carvallo JF. Functional gait disorders, clinical phenomenology, and classification. Neurol Sci. 2020 Apr; 41(4):911-915. PMID: 31832998.
      Citations: 5     Fields:    Translation:Humans
    121. Deng H, Wu S, Jankovic J. [Essential tremor: genetic update]. Expert Rev Mol Med. 2019 12 10; 21:e8. PMID: 31818346.
      Citations: 8     Fields:    Translation:HumansAnimals
    122. Bellows S, Jankovic J. Treatment of dystonia and tics. Clin Park Relat Disord. 2020; 2:12-19. PMID: 34316614; PMCID: PMC8302199.
      Citations: 1     
    123. Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA, Noyce AJ, Xue A, Bras J, Young E, von Coelln R, Krohn L, Siitonen A, Iwaki H, Leonard H, Faghri F, Gibbs JR, Hernandez DG, Scholz SW, Jankovic J, Shulman LM, Sutherland M, Tienari P, Majamaa K, Toft M, Andreassen OA, Bangale T, Yang J, Gan-Or Z, Shulman JM, Wood NW, Hinds DA, Hardy JA, Morris HR, Gratten J, Visscher PM, Graham RR, Singleton AB, 23andMe Research Team, System Genomics of Parkinson's Disease Consortium, International Parkinson's Disease Genomics Consortium, Sim?n-S?nchez J, Schulte C, Sharma M, Pihlstr?m L, Botia JA, Martinez M, Corvol JC, Lesage S, Brice A, Gasser T, Heutink P. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019 12; 18(12):1091-1102. PMID: 31701892; PMCID: PMC8422160.
      Citations: 390     Fields:    Translation:Humans
    124. Louis ED, Bares M, Fahn S, Frucht SJ, Jankovic J, Ondo WG, Pal PK, Tan EK, Benito-Leon J. Essential tremor-plus: a controversial new concept. Lancet Neurol. 2020 03; 19(3):266-270. PMID: 31767343; PMCID: PMC10686582.
      Citations: 28     Fields:    Translation:Humans
    125. Jankovic J. Reader response: High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapy. Neurology. 2019 10 22; 93(17):766-767. PMID: 31636230.
      Citations: 1     Fields:    
    126. Shoeibi A, Litvan I, Juncos JL, Bordelon Y, Riley D, Standaert D, Reich SG, Shprecher D, Hall D, Marras C, Kluger B, Olfati N, Jankovic J. Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes? Parkinsonism Relat Disord. 2019 12; 69:34-39. PMID: 31665686; PMCID: PMC6914266.
      Citations: 7     Fields:    Translation:Humans
    127. Bellows S, Jankovic J. Immunogenicity Associated with Botulinum Toxin Treatment. Toxins (Basel). 2019 08 26; 11(9). PMID: 31454941; PMCID: PMC6784164.
      Citations: 32     Fields:    Translation:HumansAnimalsCells
    128. Rabadia SV, Litvan I, Juncos J, Bordelon Y, Riley DE, Standaert D, Reich SG, Hall DA, Kluger B, Shprecher D, Marras C, Jankovic J, ENGENE PSP study. Hypertension and progressive supranuclear palsy. Parkinsonism Relat Disord. 2019 09; 66:166-170. PMID: 31420308.
      Citations: 6     Fields:    Translation:Humans
    129. Thenganatt MA, Jankovic J. Psychogenic (Functional) Movement Disorders. Continuum (Minneap Minn). 2019 Aug; 25(4):1121-1140. PMID: 31356296.
      Citations: 12     Fields:    Translation:Humans
    130. Dashtipour K, Mari Z, Jankovic J, Adler CH, Schwartz M, Brin MF. Minimal clinically important change in patients with cervical dystonia: Results from the CD PROBE study. J Neurol Sci. 2019 Oct 15; 405:116413. PMID: 31494402.
      Citations: 6     Fields:    Translation:Humans
    131. Niemann N, Jankovic J. Juvenile parkinsonism: Differential diagnosis, genetics, and treatment. Parkinsonism Relat Disord. 2019 10; 67:74-89. PMID: 31272925.
      Citations: 13     Fields:    Translation:Humans
    132. Mehanna R, Jankovic J. Young-onset Parkinson's disease: Its unique features and their impact on quality of life. Parkinsonism Relat Disord. 2019 08; 65:39-48. PMID: 31176633.
      Citations: 12     Fields:    Translation:HumansAnimals
    133. Savitt D, Jankovic J. Targeting a-Synuclein in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapeutics. Drugs. 2019 Jun; 79(8):797-810. PMID: 30982161.
      Citations: 27     Fields:    Translation:Humans
    134. Gregory A, Lotia M, Jeong SY, Fox R, Zhen D, Sanford L, Hamada J, Jahic A, Beetz C, Freed A, Kurian MA, Cullup T, van der Weijden MCM, Nguyen V, Setthavongsack N, Garcia D, Krajbich V, Pham T, Woltjer R, George BP, Minks KQ, Paciorkowski AR, Hogarth P, Jankovic J, Hayflick SJ. Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN). Mol Genet Genomic Med. 2019 07; 7(7):e00736. PMID: 31087512; PMCID: PMC6625130.
      Citations: 15     Fields:    Translation:HumansCells
    135. Savitt D, Jankovic J. Clinical phenotype in carriers of intermediate alleles in the huntingtin gene. J Neurol Sci. 2019 Jul 15; 402:57-61. PMID: 31103960.
      Citations: 6     Fields:    Translation:HumansCells
    136. Pringsheim T, Okun MS, M?ller-Vahl K, Martino D, Jankovic J, Cavanna AE, Woods DW, Robinson M, Jarvie E, Roessner V, Oskoui M, Holler-Managan Y, Piacentini J. Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019 05 07; 92(19):896-906. PMID: 31061208; PMCID: PMC6537133.
      Citations: 61     Fields:    Translation:Humans
    137. Pringsheim T, Holler-Managan Y, Okun MS, Jankovic J, Piacentini J, Cavanna AE, Martino D, Woods DW, Robinson M, Jarvie E, Roessner V, Oskoui M, M?ller-Vahl K. Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019 05 07; 92(19):907-915. PMID: 31061209; PMCID: PMC6537130.
      Citations: 44     Fields:    Translation:Humans
    138. Migliore S, Jankovic J, Squitieri F. Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon? Front Neurol. 2019; 10:453. PMID: 31114543; PMCID: PMC6503085.
      Citations: 8     
    139. Merola A, Dwivedi AK, Shaikh AG, Tareen TK, Da Prat GA, Hampf J, Mahajan A, Marsili L, Jankovic J, Comella CL, Berman BD, Perlmutter JS, Jinnah HA, Espay AJ, Kauffman MA. Head tremor at disease onset: an ataxic phenotype of cervical dystonia. J Neurol. 2019 Aug; 266(8):1844-1851. PMID: 31028543; PMCID: PMC6642013.
      Citations: 12     Fields:    Translation:Humans
    140. Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Sharma M, Krohn L, Siitonen A, Iwaki H, Leonard H, Noyce AJ, Tan M, Gibbs JR, Hernandez DG, Scholz SW, Jankovic J, Shulman LM, van Hilten JJ, Marinus J, 23andMe Research Team, Eerola-Rautio J, Tienari P, Majamaa K, Toft M, Grosset DG, Shulman JM, Wood N, Hardy J, Morris HR, Hinds DA, Gratten J, Visscher PM, Gan-Or Z, Nalls MA, Singleton AB, International Parkinson's Disease Genomics Consortium (IPDGC), Pihlstr?m L, Sim?n-S?nchez J, Schulte C, Lesage S, Corvol JC, Brice A, Gasser T, Heutink P. Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and a-synuclein mechanisms. Mov Disord. 2019 06; 34(6):866-875. PMID: 30957308; PMCID: PMC6579628.
      Citations: 105     Fields:    Translation:Humans
    141. Niemann N, Jankovic J. Real-World Experience With VMAT2 Inhibitors. Clin Neuropharmacol. 2019 Mar/Apr; 42(2):37-41. PMID: 30870235.
      Citations: 8     Fields:    Translation:Humans
    142. Yu D, Sul JH, Tsetsos F, Nawaz MS, Huang AY, Zelaya I, Illmann C, Osiecki L, Darrow SM, Hirschtritt ME, Greenberg E, Muller-Vahl KR, Stuhrmann M, Dion Y, Rouleau G, Aschauer H, Stamenkovic M, Sandor P, Barr CL, Grados M, Singer HS, Hebebrand J, Hinney A, King RA, Fernandez TV, Barta C, Tarnok Z, Nagy P, Depienne C, Worbe Y, Hartmann A, Budman CL, Rizzo R, Lyon GJ, McMahon WM, Batterson JR, Cath DC, Malaty IA, Okun MS, Berlin C, Woods DW, Lee PC, Jankovic J, Robertson MM, Gilbert DL, Brown LW, Coffey BJ, Dietrich A, Hoekstra PJ, Kuperman S, Zinner SH, Atzmon G, Barzilai N, Wagner M, Moessner R, Ophoff R, Pato CN, Pato MT, Knowles JA, Roffman JL, Smoller JW, Buckner RL, Willsey AJ, Tischfield JA, Heiman GA, Stefansson H, Posthuma D, Cox NJ, Pauls DL, Freimer NB, Neale BM, Davis LK, Paschou P, Coppola G, Mathews CA, Scharf JM, Tourette Association of America International Consortium for Genetics, the Gilles de la Tourette GWA, Schl?gelhofer M, N?then MM, Lu?vigsson P, S?mundsen E, Thorarensen ?, Stefansson K. Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies. Am J Psychiatry. 2019 03 01; 176(3):217-227. PMID: 30818990; PMCID: PMC6677250.
      Citations: 64     Fields:    Translation:Humans
    143. Wijemanne S, Jankovic J. Hand, foot, and spine deformities in parkinsonian disorders. J Neural Transm (Vienna). 2019 03; 126(3):253-264. PMID: 30809710.
      Citations: 5     Fields:    Translation:Humans
    144. Hallett M, Jankovic J, Baizabal-Carvallo JF. Pathogenesis and pathophysiology of functional (psychogenic) movement disorders. Neurobiol Dis. 2019 07; 127:32-44. PMID: 30798005.
      Citations: 36     Fields:    Translation:Humans
    145. Jankovic J, Baizabal-Carvallo JF. The Wide Spectrum of Functional Movement Disorders. JAMA Neurol. 2019 02 01; 76(2):235-236. PMID: 30535193.
      Citations:    Fields:    Translation:Humans
    146. Savitt D, Jankovic J. Levodopa-induced dyskinesias in mitochondrial membrane protein-associated neurodegeneration. Neurol Clin Pract. 2019 Feb; 9(1):e7-e9. PMID: 30859014; PMCID: PMC6382374.
      Citations: 1     
    147. Mittal SO, Lenka A, Jankovic J. Botulinum toxin for the treatment of tremor. Parkinsonism Relat Disord. 2019 06; 63:31-41. PMID: 30709779.
      Citations: 12     Fields:    Translation:Humans
    148. Tarakad A, Jankovic J. Essential Tremor and Parkinson's Disease: Exploring the Relationship. Tremor Other Hyperkinet Mov (N Y). 2018; 8:589. PMID: 30643667; PMCID: PMC6329774.
      Citations: 25     Fields:    Translation:Humans
    149. Jankovic J. Pathogenesis-targeted therapeutic strategies in Parkinson's disease. Mov Disord. 2019 01; 34(1):41-44. PMID: 30484897.
      Citations: 12     Fields:    Translation:HumansCells
    150. Parnes M, Bashir H, Jankovic J. Is Benign Hereditary Chorea Really Benign? Brain-Lung-Thyroid Syndrome Caused by NKX2-1 Mutations. Mov Disord Clin Pract. 2019 Jan; 6(1):34-39. PMID: 30746413; PMCID: PMC6335533.
      Citations: 4     
    151. Balint B, Valente EM, Pisani A, Rothwell J, Jankovic J, Vidailhet M, Bhatia KP, Mencacci NE. Author Correction: Dystonia. Nat Rev Dis Primers. 2018 Oct 19; 4(1):37. PMID: 30341354.
      Citations: 3     Fields:    
    152. Junker J, Brandt V, Berman BD, Vidailhet M, Roze E, Weissbach A, Comella C, Malaty IA, Jankovic J, LeDoux MS, Berardelli A, Barbano R, Reich SG, Perlmutter JS, Jinnah HA, Br?ggemann N. Predictors of alcohol responsiveness in dystonia. Neurology. 2018 11 20; 91(21):e2020-e2026. PMID: 30341158; PMCID: PMC6260199.
      Citations: 5     Fields:    Translation:Humans
    153. Jankovic J. Reader response: The nature of postural tremor in Parkinson disease. Neurology. 2018 10 09; 91(15):723. PMID: 30297509.
      Citations: 1     Fields:    Translation:Humans
    154. Jankovic J, Goodman I, Safirstein B, Marmon TK, Schenk DB, Koller M, Zago W, Ness DK, Griffith SG, Grundman M, Soto J, Ostrowitzki S, Boess FG, Martin-Facklam M, Quinn JF, Isaacson SH, Omidvar O, Ellenbogen A, Kinney GG. Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-a-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol. 2018 10 01; 75(10):1206-1214. PMID: 29913017; PMCID: PMC6233845.
      Citations: 81     Fields:    Translation:HumansCTClinical Trials
    155. Testa CM, Jankovic J. Huntington disease: A quarter century of progress since the gene discovery. J Neurol Sci. 2019 01 15; 396:52-68. PMID: 30419368.
      Citations: 13     Fields:    Translation:HumansCells
    156. Valente EM, Pisani A, Jankovic J, Vidailhet M, Balint B, Mencacci NE, Rothwell J, Bhatia KP. Dystonia. Nat Rev Dis Primers. 2018 09 20; 4(1):25. PMID: 30237473.
      Citations: 69     Fields:    Translation:Humans
    157. Gilbert DL, Murphy TK, Jankovic J, Budman CL, Black KJ, Kurlan RM, Coffman KA, McCracken JT, Juncos J, Grant JE, Chipkin RE. Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study. Mov Disord. 2018 08; 33(8):1272-1280. PMID: 30192018.
      Citations: 11     Fields:    Translation:Humans
    158. Larson P, Starr PA, Okun MS, Wharen RE, Uitti RJ, Guthrie BL, Peichel D, Pahwa R, Foote K, Marshall FJ, Jankovic J, Simpson R, Phibbs F, Neimat JS, Stewart RM, Dashtipour K, Mitchell KT, Walker HC, Ostrem JL. Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms. Parkinsonism Relat Disord. 2019 03; 60:126-132. PMID: 30220556.
      Citations: 14     Fields:    Translation:Humans
    159. Telkes I, Viswanathan A, Jimenez-Shahed J, Abosch A, Ozturk M, Gupte A, Jankovic J, Ince NF. Local field potentials of subthalamic nucleus contain electrophysiological footprints of motor subtypes of Parkinson's disease. Proc Natl Acad Sci U S A. 2018 09 04; 115(36):E8567-E8576. PMID: 30131429; PMCID: PMC6130371.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    160. Jankovic J. Essential Tremor. N Engl J Med. 2018 08 09; 379(6):595. PMID: 30091352.
      Citations:    Fields:    Translation:Humans
    161. Machol K, Jankovic J, Vijayakumar D, Burrage LC, Jain M, Lewis RA, Fuller GN, Xu M, Penas-Prado M, Gule-Monroe MK, Rosenfeld JA, Chen R, Eng CM, Yang Y, Lee BH, Moretti PM, Undiagnosed Diseases Network, Dhar SU. Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma. Neurol Genet. 2018 Aug; 4(4):e248. PMID: 30046660; PMCID: PMC6055357.
      Citations: 4     
    162. Niemann N, Jankovic J. Botulinum Toxin for the Treatment of Hand Tremor. Toxins (Basel). 2018 07 19; 10(7). PMID: 30029483; PMCID: PMC6070882.
      Citations: 15     Fields:    Translation:Humans
    163. Bashir H, Jankovic J. Deutetrabenazine for the treatment of Huntington's chorea. Expert Rev Neurother. 2018 08; 18(8):625-631. PMID: 29996061.
      Citations: 1     Fields:    Translation:Humans
    164. Margraf NG, Wolke R, Granert O, Berardelli A, Bloem BR, Djaldetti R, Espay AJ, Fasano A, Furusawa Y, Giladi N, Hallett M, Jankovic J, Murata M, Tinazzi M, Berg D, Volkmann J, Deuschl G. Consensus for the measurement of the camptocormia angle in the standing patient. Parkinsonism Relat Disord. 2018 07; 52:1-5. PMID: 29907329.
      Citations: 11     Fields:    Translation:Humans
    165. Jankovic J, Truong D, Patel AT, Brashear A, Evatt M, Rubio RG, Oh CK, Snyder D, Shears G, Comella C. Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study. Mov Disord Clin Pract. 2018 May-Jun; 5(3):273-282. PMID: 30009213; PMCID: PMC6032882.
      Citations: 15     
    166. Niemann N, Jankovic J. Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors. Drugs. 2018 04; 78(5):525-541. PMID: 29484607.
      Citations: 6     Fields:    Translation:Humans
    167. Niemann N, Jankovic J. Correction to: Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors. Drugs. 2018 04; 78(5):609. PMID: 29524074.
      Citations:    Fields:    
    168. Jankovic J, Marsh L, Patel A, Jinnah HA, Comella C, Barbano R, Perlmutter J, members of the Dystonia Coalition, Mahajan A, Patel N. Cervical dystonia and substance abuse. J Neurol. 2018 Apr; 265(4):970-975. PMID: 29569175.
      Citations: 2     Fields:    Translation:Humans
    169. Albanese A, Cardoso F, Fujinaga Y, Jankovic J, Schiavo G, Rummel A. Toxins 2017 conference in Madrid. Toxicon. 2018 Jun 01; 147:1. PMID: 30837060.
      Citations:    Fields:    
    170. Jankovic J. Parkinson's disease tremors and serotonin. Brain. 2018 03 01; 141(3):624-626. PMID: 30063797.
      Citations: 3     Fields:    Translation:Humans
    171. Park HK, Ilango S, Charriez CM, Checkoway H, Riley D, Standaert DG, Bordelon Y, Shprecher DR, Reich SG, Hall D, Kluger B, Marras C, Jankovic J, Dubinsky R, Litvan I, ENGENE-PSP Study. Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study. Mov Disord. 2018 03; 33(3):468-472. PMID: 29460982; PMCID: PMC5840026.
      Citations: 9     Fields:    Translation:Humans
    172. Frei K, Truong DD, Fahn S, Jankovic J, Hauser RA. The nosology of tardive syndromes. J Neurol Sci. 2018 06 15; 389:10-16. PMID: 29433810.
      Citations: 11     Fields:    Translation:Humans
    173. Savitt D, Jankovic J. Tardive syndromes. J Neurol Sci. 2018 06 15; 389:35-42. PMID: 29506749.
      Citations: 19     Fields:    Translation:Humans
    174. Jankovic J. Immunologic treatment of Parkinson's disease. Immunotherapy. 2018 02; 10(2):81-84. PMID: 29260621.
      Citations: 4     Fields:    Translation:HumansAnimals
    175. Ondo WG, Simmons JH, Shahid MH, Hashem V, Hunter C, Jankovic J. Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study. Neurology. 2018 02 13; 90(7):e559-e564. PMID: 29343468.
      Citations: 9     Fields:    Translation:Humans
    176. Lotia M, York MK, Strutt AM, Jankovic J. Leg stereotypy syndrome: phenomenology and prevalence. J Neurol Neurosurg Psychiatry. 2018 07; 89(7):692-695. PMID: 29332008.
      Citations: 1     Fields:    Translation:Humans
    177. Deng H, Fan K, Jankovic J. The Role of TMEM230 Gene in Parkinson's Disease. J Parkinsons Dis. 2018; 8(4):469-477. PMID: 30175983; PMCID: PMC6218139.
      Citations: 3     Fields:    Translation:Humans
    178. Jankovic J, Baizabal-Carvallo JF. Autoimmune and paraneoplastic movement disorders: An update. J Neurol Sci. 2018 02 15; 385:175-184. PMID: 29406902.
      Citations: 22     Fields:    Translation:Humans
    179. Deng H, Wang P, Jankovic J. The genetics of Parkinson disease. Ageing Res Rev. 2018 Mar; 42:72-85. PMID: 29288112.
      Citations: 148     Fields:    Translation:HumansAnimalsCells
    180. Robak LA, van Rooij J, Kraaij R, Jankovic J, Shulman JM, Jansen IE, Uitterlinden AG, International Parkinson?s Disease Genomics Consortium (IPDGC), Heutink P. Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease. Brain. 2017 12 01; 140(12):3191-3203. PMID: 29140481; PMCID: PMC5841393.
      Citations: 131     Fields:    Translation:Humans
    181. Bashir H, Jankovic J. Treatment options for chorea. Expert Rev Neurother. 2018 Jan; 18(1):51-63. PMID: 29120264.
      Citations: 11     Fields:    Translation:Humans
    182. Pulliam CL, Jankovic J, Ramirez-Castaneda JL, Heldman DA, Vittal P, Goetz CG, Ouyang B. Does Added Objective Tremor Monitoring Improve Clinical Outcomes in Essential Tremor Treatment? Mov Disord Clin Pract. 2018 Jan-Feb; 5(1):96-98. PMID: 30746399; PMCID: PMC6336186.
      Citations: 2     
    183. Jankovic J. Parkinson disease: Exenatide - a drug for diabetes and Parkinson disease? Nat Rev Neurol. 2017 Nov; 13(11):643-644. PMID: 28960185.
      Citations: 6     Fields:    Translation:Humans
    184. Oshima M, Deitiker P, Jankovic J, Atassi MZ. The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule. Immunol Invest. 2018 Jan; 47(1):18-39. PMID: 28891721.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    185. Jankovic J. An update on new and unique uses of botulinum toxin in movement disorders. Toxicon. 2018 Jun 01; 147:84-88. PMID: 28888928.
      Citations: 28     Fields:    Translation:Humans
    186. Jinnah HA, Albanese A, Bhatia KP, Cardoso F, Da Prat G, de Koning TJ, Espay AJ, Fung V, Garcia-Ruiz PJ, Gershanik O, Jankovic J, Kaji R, Kotschet K, Marras C, Miyasaki JM, Morgante F, Pal PK, Rodriguez Oroz MC, Stamelou M, Tijssen M, Uribe Roca C, de la Cerda A, Gatto EM, International Parkinson's Disease Movement Disorders Society Task Force on Rare Movement Disorders, Munchau A, Rodr?guez-Violante M, Sch?ls L. Treatable inherited rare movement disorders. Mov Disord. 2018 01; 33(1):21-35. PMID: 28861905; PMCID: PMC5921079.
      Citations: 23     Fields:    Translation:Humans
    187. Jankovic J. Statin-related musculoskeletal pain in Parkinson's disease. Pain. 2017 09; 158(9):1840. PMID: 28816887.
      Citations: 1     Fields:    
    188. Deitiker P, Oshima M, Jankovic J, Atassi MZ. Influences of HLA DRB1, DQA1 and DQB1 on T-cell recognition of epitopes and of larger regions of the botulinum neurotoxin molecule. Immunol Lett. 2017 10; 190:257-264. PMID: 28823519.
      Citations:    Fields:    Translation:HumansCells
    189. Frank S, Stamler D, Kayson E, Claassen DO, Colcher A, Davis C, Duker A, Eberly S, Elmer L, Furr-Stimming E, Gudesblatt M, Hunter C, Jankovic J, Kostyk SK, Kumar R, Loy C, Mallonee W, Oakes D, Scott BL, Sung V, Goldstein J, Vaughan C, Testa CM, Huntington Study Group/Alternatives for Reducing Chorea in Huntington Disease Investigators. Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea. JAMA Neurol. 2017 08 01; 74(8):977-982. PMID: 28692723; PMCID: PMC5710322.
      Citations: 11     Fields:    Translation:Humans
    190. Rousseaux MWC, Shulman JM, Jankovic J. Progress toward an integrated understanding of Parkinson's disease. F1000Res. 2017; 6:1121. PMID: 28751973; PMCID: PMC5510019.
      Citations: 11     Fields:    
    191. Tarakad A, Jankovic J. Anosmia and Ageusia in Parkinson's Disease. Int Rev Neurobiol. 2017; 133:541-556. PMID: 28802932.
      Citations: 27     Fields:    Translation:Humans
    192. Jankovic J, Baizabal-Carvallo JF. Functional (psychogenic) stereotypies. J Neurol. 2017 Jul; 264(7):1482-1487. PMID: 28653211.
      Citations: 4     Fields:    Translation:Humans
    193. Jankovic J. Botulinum toxin: State of the art. Mov Disord. 2017 Aug; 32(8):1131-1138. PMID: 28639368.
      Citations: 54     Fields:    Translation:HumansAnimals
    194. Tarakad A, Jankovic J. Diagnosis and Management of Parkinson's Disease. Semin Neurol. 2017 04; 37(2):118-126. PMID: 28511252.
      Citations: 31     Fields:    Translation:Humans
    195. Carecchio M, Iodice A, Pons R, Panteghini C, Zorzi G, Zibordi F, Bonakis A, Dinopoulos A, Jankovic J, Stefanis L, Bhatia KP, Monti V, R'Bibo L, Veneziano L, Garavaglia B, Fusco C, Wood N, Stamelou M, Nardocci N, Mencacci NE. ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients. Parkinsonism Relat Disord. 2017 Aug; 41:37-43. PMID: 28511835; PMCID: PMC5549507.
      Citations: 20     Fields:    Translation:Humans
    196. Pirio Richardson S, Alter K, Alterman RL, Chen R, Frucht S, Furuya S, Jankovic J, Jinnah HA, Kimberley TJ, Lungu C, Perlmutter JS, Hallett M, Altenm?ller E, Prudente CN. Research Priorities in Limb and Task-Specific Dystonias. Front Neurol. 2017; 8:170. PMID: 28515706; PMCID: PMC5413505.
      Citations: 13     
    197. Berman BD, Junker J, Shelton E, Sillau SH, Jinnah HA, Perlmutter JS, Espay AJ, Jankovic J, Ondo W, Malaty IA, McDonald WM, Marsh L, Zurowski M, Vidailhet M, Bonnet C, Rodr?guez R, B?umer T, Br?ggemann N. Psychiatric associations of adult-onset focal dystonia phenotypes. J Neurol Neurosurg Psychiatry. 2017 07; 88(7):595-602. PMID: 28438790; PMCID: PMC5659143.
      Citations: 25     Fields:    Translation:Humans
    198. Robledo I, Jankovic J. Media hype: Patient and scientific perspectives on misleading medical news. Mov Disord. 2017 Sep; 32(9):1319-1323. PMID: 28370445.
      Citations: 13     Fields:    Translation:Humans
    199. Wharen RE, Okun MS, Guthrie BL, Uitti RJ, Larson P, Foote K, Walker H, Marshall FJ, Schwalb J, Ford B, Jankovic J, Simpson R, Dashtipour K, Phibbs F, Neimat JS, Stewart RM, Peichel D, Pahwa R, Ostrem JL, SJM DBS ET Study Group. Thalamic DBS with a constant-current device in essential tremor: A?controlled clinical trial. Parkinsonism Relat Disord. 2017 Jul; 40:18-26. PMID: 28400200.
      Citations: 16     Fields:    Translation:Humans
    200. Wijemanne S, Vijayakumar D, Jankovic J. Apraclonidine in the treatment of ptosis. J Neurol Sci. 2017 May 15; 376:129-132. PMID: 28431598.
      Citations: 5     Fields:    Translation:Humans
    201. Kanaan RAA, Duncan R, Goldstein LH, Jankovic J, Cavanna AE. Are psychogenic non-epileptic seizures just another symptom of conversion disorder? J Neurol Neurosurg Psychiatry. 2017 05; 88(5):425-429. PMID: 28235779.
      Citations: 9     Fields:    Translation:Humans
    202. Schapira AH, Fox SH, Hauser RA, Jankovic J, Jost WH, Kenney C, Pahwa R, Poewe W, Anand R, Kulisevsky J. Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial. JAMA Neurol. 2017 Feb 01; 74(2):216-224. PMID: 27942720.
      Citations: 40     Fields:    Translation:Humans
    203. Jankovic J, Squitieri F. Letter re: Huntington disease reduced penetrance alleles occur at high frequency in the general population. Neurology. 2017 01 17; 88(3):334. PMID: 28093514.
      Citations:    Fields:    Translation:HumansCells
    204. Jankovic J. Movement disorders in 2016: Progress in Parkinson disease and other movement disorders. Nat Rev Neurol. 2017 Feb; 13(2):76-78. PMID: 28084323.
      Citations: 9     Fields:    Translation:Humans
    205. Jankovic J, Baizabal-Carvallo JF. Examiner manoeuvres 'sensory tricks' in functional (psychogenic) movement disorders. J Neurol Neurosurg Psychiatry. 2017 05; 88(5):453-455. PMID: 27986829.
      Citations: 2     Fields:    Translation:Humans
    206. Bluett B, Litvan I, Cheng S, Juncos J, Riley DE, Standaert DG, Reich SG, Hall DA, Kluger B, Shprecher D, Marras C, Jankovic J, ENGENE PSP study. Understanding falls in progressive supranuclear palsy. Parkinsonism Relat Disord. 2017 02; 35:75-81. PMID: 28007518.
      Citations: 6     Fields:    Translation:Humans
    207. Jankovic J, Baizabal-Carvallo JF. Distinguishing features of psychogenic (functional) versus organic hemifacial spasm. J Neurol. 2017 Feb; 264(2):359-363. PMID: 27942912.
      Citations: 5     Fields:    Translation:Humans
    208. McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M, Huntington Study Group 2CARE Investigators and Coordinators. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. 2017 Jan 10; 88(2):152-159. PMID: 27913695; PMCID: PMC5224719.
      Citations: 42     Fields:    Translation:Humans
    209. Jankovic J. Dopamine depleters in the treatment of hyperkinetic movement disorders. Expert Opin Pharmacother. 2016 Dec; 17(18):2461-2470. PMID: 27819145.
      Citations: 33     Fields:    Translation:HumansAnimals
    210. Jankovic J, Albanese A. Editorial: Toxins 2017. Toxicon. 2016 Dec 25; 123S:S1. PMID: 27889226.
      Citations:    Fields:    
    211. Vijayakumar D, Wijemanne S, Jankovic J. Treatment of blepharospasm with apraclonidine. J Neurol Sci. 2017 Jan 15; 372:57-59. PMID: 28017248.
      Citations: 2     Fields:    Translation:Humans
    212. Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, Stamler D. Deutetrabenazine in Tics Associated with Tourette Syndrome. Tremor Other Hyperkinet Mov (N Y). 2016; 6:422. PMID: 27917309; PMCID: PMC5133390.
      Citations: 18     Fields:    
    213. Hopfner F, Clark LN, Tittmann L, Soto-Ortolaza AI, Hallett M, Schneider SA, Hodgkinson CA, Lieb W, Wszolek ZK, Pendziwiat M, Lorenzo-Betancor O, Poewe W, Ortega-Cubero S, Seppi K, Rajput A, Hussl A, Rajput AH, Berg D, Shulman JM, Haubenberger D, Pastor P, Jankovic J, Testa CM, Zeuner KE, Ross OA, Louis ED, M?ller SH, Girard SL, Merner ND, Bourassa CV, Lorenz D, Klebe S, Dion PA, Wurster I, Srulijes K, Vilari?o-G?ell C, Postuma RB, Bernard G, Ladwig KH, Dupr? N, Strauch K, Panisset M, Winkelmann J, Reischl E, Arzberger T, Chouinard S, Deuschl G, Kuhlenb?umer G, Rouleau GA. Genome-wide association study in essential tremor identifies three new loci. Brain. 2016 12; 139(Pt 12):3163-3169. PMID: 27797806; PMCID: PMC5382938.
      Citations: 32     Fields:    Translation:Humans
    214. Jankovic J, Tagliati M, Peichel D, Okun MS, Tr?ster AI. Neuropsychological outcomes from constant current deep brain stimulation for Parkinson's disease. Mov Disord. 2017 03; 32(3):433-440. PMID: 27753157; PMCID: PMC5363377.
      Citations: 22     Fields:    Translation:Humans
    215. Oshima M, Deitiker P, Jankovic J, Atassi MZ. Submolecular recognition regions of the HN domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients. J Neuroimmunol. 2016 11 15; 300:36-46. PMID: 27806874.
      Citations: 2     Fields:    Translation:HumansCells
    216. Albanese A, Bhatia K, DeLong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Mink JW, Teller JK. "Complex" dystonia is not a category in the new 2013 consensus classification. Mov Disord. 2016 11; 31(11):1758-1759. PMID: 27612445; PMCID: PMC5983033.
      Citations: 1     Fields:    Translation:Humans
    217. Huntington Study Group, Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E, Chouinard S, Beland M. Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. JAMA. 2016 Jul 05; 316(1):40-50. PMID: 27380342.
      Citations: 48     Fields:    Translation:Humans
    218. Jankovic J, Baizabal-Carvallo JF. Functional (psychogenic) saccadic oscillations and oculogyric crises. Lancet Neurol. 2016 07; 15(8):791. PMID: 27302355.
      Citations:    Fields:    Translation:Humans
    219. Deng HX, Shi Y, Yang Y, Ahmeti KB, Miller N, Huang C, Cheng L, Zhai H, Deng S, Nuytemans K, Corbett NJ, Kim MJ, Deng H, Tang B, Yang Z, Xu Y, Chan P, Huang B, Gao XP, Song Z, Liu Z, Fecto F, Siddique N, Foroud T, Jankovic J, Ghetti B, Nicholson DA, Krainc D, Melen O, Vance JM, Pericak-Vance MA, Ma YC, Rajput AH, Siddique T. Identification of TMEM230 mutations in familial Parkinson's disease. Nat Genet. 2016 07; 48(7):733-9. PMID: 27270108; PMCID: PMC6047531.
      Citations: 64     Fields:    Translation:HumansCells
    220. Vijayakumar D, Jankovic J. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia. Drugs. 2016 May; 76(7):779-87. PMID: 27091214.
      Citations: 14     Fields:    Translation:Humans
    221. Vijayakumar D, Jankovic J. Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia. Drugs. 2016 May; 76(7):759-77. PMID: 27091215.
      Citations: 33     Fields:    Translation:Humans
    222. Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, Armstrong MJ, Gloss D, Potrebic S, Jankovic J, Karp BP, Naumann M, So YT, Yablon SA. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016 May 10; 86(19):1818-26. PMID: 27164716; PMCID: PMC4862245.
      Citations: 165     Fields:    Translation:Humans
    223. LeDoux MS, Vemula SR, Xiao J, Thompson MM, Perlmutter JS, Wright LJ, Jinnah HA, Rosen AR, Hedera P, Comella CL, Weissbach A, Junker J, Jankovic J, Barbano RL, Reich SG, Rodriguez RL, Berman BD, Chouinard S, Severt L, Agarwal P, Stover NP. Clinical and genetic features of cervical dystonia in a large multicenter cohort. Neurol Genet. 2016 Jun; 2(3):e69. PMID: 27123488; PMCID: PMC4830199.
      Citations: 20     
    224. Comella CL, Perlmutter JS, Jinnah HA, Waliczek TA, Rosen AR, Galpern WR, Adler CA, Barbano RL, Factor SA, Goetz CG, Jankovic J, Reich SG, Rodriguez RL, Severt WL, Zurowski M, Fox SH, Stebbins GT. Clinimetric testing of the comprehensive cervical dystonia rating scale. Mov Disord. 2016 Apr; 31(4):563-9. PMID: 26971359; PMCID: PMC4833533.
      Citations: 15     Fields:    Translation:Humans
    225. Jankovic J, Baizabal-Carvallo JF. Parkinsonism, movement disorders and genetics in frontotemporal dementia. Nat Rev Neurol. 2016 Mar; 12(3):175-85. PMID: 26891767.
      Citations: 35     Fields:    Translation:HumansAnimals
    226. Lotia M, Jankovic J. New and emerging medical therapies in Parkinson's disease. Expert Opin Pharmacother. 2016; 17(7):895-909. PMID: 26830844.
      Citations: 10     Fields:    Translation:Humans
    227. Lotia M, Jankovic J. Botulinum Toxin for the Treatment of Tremor and Tics. Semin Neurol. 2016 Feb; 36(1):54-63. PMID: 26866497.
      Citations: 6     Fields:    Translation:HumansAnimals
    228. Thenganatt MA, Jankovic J. Recent Advances in Understanding and Managing Tourette Syndrome. F1000Res. 2016; 5. PMID: 26918185; PMCID: PMC4755417.
      Citations: 17     Fields:    
    229. Jankovic J. How Do I Examine for Re-Emergent Tremor? Mov Disord Clin Pract. 2016 Mar-Apr; 3(2):216-217. PMID: 30363601; PMCID: PMC6178735.
      Citations: 3     
    230. Jankovic J, Baizabal-Carvallo JF. Psychogenic Ophthalmologic Movement Disorders. J Neuropsychiatry Clin Neurosci. 2016; 28(3):195-8. PMID: 26792096.
      Citations: 2     Fields:    Translation:Humans
    231. Jankovic J, Baizabal-Carvallo JF. Movement disorders induced by deep brain stimulation. Parkinsonism Relat Disord. 2016 Apr; 25:1-9. PMID: 26806438.
      Citations: 25     Fields:    Translation:Humans
    232. Huntington Study Group PHAROS Investigators, Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D, Kostyk S, Baic C, Caress J, Walker F, Hunt V, O'Neill C, Chouinard S, Factor S, Greenamyre T, Wood-Siverio C, Corey-Bloom J, Song D, Peavy G, Moskowitz C, Wesson M, Samii A, Bird T, Lipe H, Blindauer K, Marshall F, Zimmerman C, Goldstein J, Rosas D, Novak P, Caviness J, Adler C, Duffy A, Wheelock V, Tempkin T, Richman D, Seeberger L, Albin R, Chou KL, Racette B, Perlmutter JS, Perlman S, Bordelon Y, Martin W, Wieler M, Leavitt B, Raymond L, Decolongon J, Clarke L, Jankovic J, Hunter C, Hauser RA, Sanchez-Ramos J, Furtado S, Suchowersky O, Klimek ML, Guttman M, Sethna R, Feigin A, Cox M, Shannon B, Percy A, Dure L, Harrison M, Johnson W, Higgins D, Molho E, Nickerson C, Evans S, Hobson D, Singer C, Galvez-Jimenez N, Shannon K, Comella C, Ross C, Saint-Hilaire MH, Testa C, Rosenblatt A, Hogarth P, Weiner W, Como P, Kumar R, Cotto C, Stout J, Brocht A, Watts A, Eberly S, Weaver C, Foroud T, Gusella J, MacDonald M, Myers R, Fahn S, Shults C. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. JAMA Neurol. 2016 Jan; 73(1):102-10. PMID: 26569098.
      Citations: 22     Fields:    Translation:HumansCells
    233. Farlow JL, Robak LA, Hetrick K, Bowling K, Boerwinkle E, Coban-Akdemir ZH, Gambin T, Gibbs RA, Gu S, Jain P, Jankovic J, Jhangiani S, Kaw K, Lai D, Lin H, Ling H, Liu Y, Lupski JR, Muzny D, Porter P, Pugh E, White J, Doheny K, Myers RM, Shulman JM, Foroud T. Whole-Exome Sequencing in Familial Parkinson Disease. JAMA Neurol. 2016 Jan; 73(1):68-75. PMID: 26595808; PMCID: PMC4946647.
      Citations: 33     Fields:    Translation:Humans
    234. Thenganatt MA, Jankovic J. Psychogenic (functional) parkinsonism. Handb Clin Neurol. 2016; 139:259-262. PMID: 27719845.
      Citations: 2     Fields:    Translation:Humans
    235. Molho ES, Stacy M, Gillard P, Charles D, Adler CH, Jankovic J, Schwartz M, Brin MF. Impact of Cervical Dystonia on Work Productivity: An Analysis From a Patient Registry. Mov Disord Clin Pract. 2016 Mar-Apr; 3(2):130-138. PMID: 27774495; PMCID: PMC5064605.
      Citations: 16     
    236. Oshima M, Deitiker P, Jankovic J, Aoki KR, Atassi MZ. Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients. Immunobiology. 2016 Apr; 221(4):568-76. PMID: 26701846.
      Citations: 1     Fields:    Translation:HumansCells
    237. Thenganatt MA, Jankovic J. Response to Shill and colleagues. Parkinsonism Relat Disord. 2016 Feb; 23:108. PMID: 26639977.
      Citations:    Fields:    
    238. Wijemanne S, Jankovic J, Evans RW. Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine. Headache. 2016 Jan; 56(1):153-61. PMID: 26573884.
      Citations: 7     Fields:    Translation:Humans
    239. Ashoori A, Eagleman DM, Jankovic J. Effects of Auditory Rhythm and Music on Gait Disturbances in Parkinson's Disease. Front Neurol. 2015; 6:234. PMID: 26617566; PMCID: PMC4641247.
      Citations: 27     
    240. Jankovic J, Bressman S, Dauer W, Kang UJ. Clinical and scientific perspectives on movement disorders: Stanley Fahn's contributions. Mov Disord. 2015 Dec; 30(14):1862-9. PMID: 26477883.
      Citations: 3     Fields:    Translation:Humans
    241. Thenganatt MA, Jankovic J. The relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord. 2016 Jan; 22 Suppl 1:S162-5. PMID: 26522219.
      Citations: 39     Fields:    Translation:HumansAnimals
    242. Jankovic J. Therapeutic Developments for Tics and Myoclonus. Mov Disord. 2015 Sep 15; 30(11):1566-73. PMID: 26315614.
      Citations: 12     Fields:    Translation:Humans
    243. Schuff N, Wu IW, Buckley S, Foster ED, Coffey CS, Gitelman DR, Mendick S, Seibyl J, Simuni T, Zhang Y, Jankovic J, Hunter C, Tanner CM, Rees L, Factor S, Berg D, Wurster I, Gauss K, Sprenger F, Seppi K, Poewe W, Mollenhauer B, Knake S, Mari Z, McCoy A, Ranola M, Marek K. Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits. Mov Disord. 2015 Dec; 30(14):1885-92. PMID: 26260437.
      Citations: 31     Fields:    Translation:Humans
    244. Jankovic J. Leg stereotypy disorder. J Neurol Neurosurg Psychiatry. 2016 Feb; 87(2):220-1. PMID: 26209715.
      Citations: 2     Fields:    Translation:Humans
    245. Byrne S, Walsh C, Hacohen Y, Muscal E, Jankovic J, Stocco A, Dale RC, Vincent A, Lim M, King M. Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e130. PMID: 26236759; PMCID: PMC4516400.
      Citations: 26     Fields:    
    246. Jankovic J, Baizabal-Carvallo JF. Speech and voice disorders in patients with psychogenic movement disorders. J Neurol. 2015 Nov; 262(11):2420-4. PMID: 26194199.
      Citations: 8     Fields:    Translation:Humans
    247. Waln O, Wu Y, Perlman R, Wendt J, Van AK, Jankovic J. Dopamine transporter imaging in essential tremor with and without parkinsonian features. J Neural Transm (Vienna). 2015 Nov; 122(11):1515-21. PMID: 26133163.
      Citations: 8     Fields:    Translation:Humans
    248. Feng Y, Liu T, Dong SY, Guo YJ, Jankovic J, Xu H, Wu YC. Rotenone affects p53 transcriptional activity and apoptosis via targeting SIRT1 and H3K9 acetylation in SH-SY5Y cells. J Neurochem. 2015 Aug; 134(4):668-76. PMID: 25991017.
      Citations: 34     Fields:    Translation:HumansCells
    249. Wijemanne S, Jankovic J. Dopa-responsive dystonia--clinical and genetic heterogeneity. Nat Rev Neurol. 2015 Jul; 11(7):414-24. PMID: 26100751.
      Citations: 59     Fields:    Translation:Humans
    250. Warren Olanow C, Bartus RT, Baumann TL, Factor S, Boulis N, Stacy M, Turner DA, Marks W, Larson P, Starr PA, Jankovic J, Simpson R, Watts R, Guthrie B, Poston K, Henderson JM, Stern M, Baltuch G, Goetz CG, Herzog C, Kordower JH, Alterman R, Lozano AM, Lang AE. Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. Ann Neurol. 2015 Aug; 78(2):248-57. PMID: 26061140.
      Citations: 99     Fields:    Translation:HumansCells
    251. Calleo JS, Amspoker AB, Sarwar AI, Kunik ME, Jankovic J, Marsh L, York M, Stanley MA. A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients With Parkinson Disease. J Geriatr Psychiatry Neurol. 2015 Sep; 28(3):210-7. PMID: 26047635.
      Citations: 14     Fields:    Translation:Humans
    252. Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, Mandrekar J. Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol. 2015 Jul; 14(7):710-9. PMID: 26025783; PMCID: PMC4472464.
      Citations: 93     Fields:    Translation:Humans
    253. Wijemanne S, Shulman JM, Jimenez-Shahed J, Curry D, Jankovic J. SPG11 Mutations Associated With a Complex Phenotype Resembling Dopa-Responsive Dystonia. Mov Disord Clin Pract. 2015 Jun; 2(2):149-154. PMID: 30363882; PMCID: PMC6183009.
      Citations: 4     
    254. Deng H, Zheng W, Jankovic J. Genetics and molecular biology of brain calcification. Ageing Res Rev. 2015 Jul; 22:20-38. PMID: 25906927.
      Citations: 14     Fields:    Translation:HumansCells
    255. Jost WH, Benecke R, Hauschke D, Jankovic J, Simpson DM, Comella CL, Kanovsk? P, Roggenk?mper P. Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders. Drug Des Devel Ther. 2015; 9:1913-26. PMID: 25897202; PMCID: PMC4389813.
      Citations: 10     Fields:    Translation:Humans
    256. Wijemanne S, Jankovic J. Restless legs syndrome: clinical presentation diagnosis and treatment. Sleep Med. 2015 Jun; 16(6):678-90. PMID: 25979181.
      Citations: 11     Fields:    Translation:Humans
    257. Kluger B, Triolo P, Jones W, Jankovic J. The therapeutic potential of cannabinoids for movement disorders. Mov Disord. 2015 Mar; 30(3):313-27. PMID: 25649017; PMCID: PMC4357541.
      Citations: 28     Fields:    Translation:HumansAnimals
    258. Jankovic J. Movement disorders. Neurol Clin. 2015 Feb; 33(1):xv-xvi. PMID: 25432734.
      Citations:    Fields:    Translation:Humans
    259. Waln O, Jankovic J. Paroxysmal movement disorders. Neurol Clin. 2015 Feb; 33(1):137-52. PMID: 25432727.
      Citations: 16     Fields:    Translation:Humans
    260. Thenganatt MA, Jankovic J. Psychogenic movement disorders. Neurol Clin. 2015 Feb; 33(1):205-24. PMID: 25432730.
      Citations: 20     Fields:    Translation:Humans
    261. Jankovic J. Gait disorders. Neurol Clin. 2015 Feb; 33(1):249-68. PMID: 25432732.
      Citations: 14     Fields:    Translation:Humans
    262. Baizabal-Carvallo JF, Xia G, Botros P, Laguna J, Ashizawa T, Jankovic J. Bolivian kindred with combined spinocerebellar ataxia types 2 and 10. Acta Neurol Scand. 2015 Aug; 132(2):139-42. PMID: 25630585; PMCID: PMC4496286.
      Citations: 6     Fields:    Translation:HumansCells
    263. Jankovic J, Adler CH, Charles D, Comella C, Stacy M, Schwartz M, Manack Adams A, Brin MF. Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE). J Neurol Sci. 2015 Feb 15; 349(1-2):84-93. PMID: 25595221.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    264. Feng Y, Jankovic J, Wu YC. Epigenetic mechanisms in Parkinson's disease. J Neurol Sci. 2015 Feb 15; 349(1-2):3-9. PMID: 25553963.
      Citations: 41     Fields:    Translation:HumansCells
    265. Jankovic J, Baizabal-Carvallo JF. Stiff-person syndrome: insights into a complex autoimmune disorder. J Neurol Neurosurg Psychiatry. 2015 Aug; 86(8):840-8. PMID: 25511790.
      Citations: 42     Fields:    Translation:Humans
    266. Cardoso F, Jankovic J, Baizabal-Carvallo JF. Myorhythmia: phenomenology, etiology, and treatment. Mov Disord. 2015 Feb; 30(2):171-9. PMID: 25487777.
      Citations: 20     Fields:    Translation:HumansAnimals
    267. Inzelberg R, Hassin-Baer S, Jankovic J. Genetic movement disorders in patients of Jewish ancestry. JAMA Neurol. 2014 Dec; 71(12):1567-72. PMID: 25347348.
      Citations: 5     Fields:    Translation:Humans
    268. Fekete R, Jankovic J. Upper facial chorea in Huntington disease. J Clin Mov Disord. 2014; 1:7. PMID: 26788333; PMCID: PMC4711000.
      Citations: 5     
    269. Wijemanne S, Jankovic J. Movement disorders in catatonia. J Neurol Neurosurg Psychiatry. 2015 Aug; 86(8):825-32. PMID: 25411548.
      Citations: 5     Fields:    Translation:Humans
    270. Jankovic J, Sherer T. The future of research in Parkinson disease. JAMA Neurol. 2014 Nov; 71(11):1351-2. PMID: 25178587.
      Citations: 14     Fields:    Translation:HumansAnimals
    271. Yu D, Mathews CA, Scharf JM, Neale BM, Davis LK, Gamazon ER, Derks EM, Evans P, Edlund CK, Crane J, Fagerness JA, Osiecki L, Gallagher P, Gerber G, Haddad S, Illmann C, McGrath LM, Mayerfeld C, Arepalli S, Barlassina C, Barr CL, Bellodi L, Benarroch F, Bienvenu OJ, Black DW, Bloch MH, Brentani H, Bruun RD, Budman CL, Camarena B, Campbell DD, Cappi C, Silgado JC, Cavallini MC, Chavira DA, Chouinard S, Cook EH, Cookson MR, Coric V, Cullen B, Cusi D, Delorme R, Denys D, Dion Y, Eapen V, Egberts K, Falkai P, Fernandez T, Fournier E, Garrido H, Geller D, Gilbert DL, Girard SL, Grabe HJ, Grados MA, Greenberg BD, Gross-Tsur V, Hardy J, Heiman GA, Hemmings SM, Herrera LD, Hezel DM, Hoekstra PJ, Jankovic J, Kennedy JL, King RA, Konkashbaev AI, Kremeyer B, Kurlan R, Lanzagorta N, Leboyer M, Leckman JF, Lennertz L, Liu C, Lochner C, Lowe TL, Lupoli S, Macciardi F, Maier W, Manunta P, Marconi M, McCracken JT, Mesa Restrepo SC, Moessner R, Moorjani P, Morgan J, Muller H, Murphy DL, Naarden AL, Nurmi E, Ochoa WC, Ophoff RA, Pakstis AJ, Pato MT, Pato CN, Piacentini J, Pittenger C, Pollak Y, Rauch SL, Renner T, Reus VI, Richter MA, Riddle MA, Robertson MM, Romero R, Rosenberg D, Ruhrmann S, Sabatti C, Salvi E, Sampaio AS, Samuels J, Sandor P, Service SK, Sheppard B, Singer HS, Smit JH, Stein DJ, Strengman E, Tischfield JA, Turiel M, Valencia Duarte AV, Vallada H, Veenstra-VanderWeele J, Walitza S, Wang Y, Weale M, Weiss R, Wendland JR, Westenberg HG, Shugart YY, Hounie AG, Miguel EC, Nicolini H, Wagner M, Ruiz-Linares A, Cath DC, McMahon W, Posthuma D, Oostra BA, Nestadt G, Rouleau GA, Purcell S, Jenike MA, Heutink P, Hanna GL, Conti DV, Arnold PD, Freimer NB, Stewart SE, Knowles JA, Cox NJ, Pauls DL, Berri? GB, Gr?nblatt E, Ros?rio MC. Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry. 2015 Jan; 172(1):82-93. PMID: 25158072; PMCID: PMC4282594.
      Citations: 47     Fields:    Translation:Humans
    272. Factor SA, Jankovic J. Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine. Neurology. 2014 Oct 07; 83(15):1388-9. PMID: 25288700.
      Citations: 3     Fields:    Translation:Humans
    273. Black KJ, Jankovic J, Hershey T, McNaught KS, Mink JW, Walkup J. Progress in research on Tourette syndrome. J Obsessive Compuls Relat Disord. 2014 Oct 01; 3(4):359-362. PMID: 25436182; PMCID: PMC4243166.
      Citations: 5     
    274. Giladi N, Ghys L, Surmann E, Boroojerdi B, Jankovic J. Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's disease. Parkinsonism Relat Disord. 2014 Dec; 20(12):1345-51. PMID: 25444083.
      Citations: 8     Fields:    Translation:Humans
    275. Jankovic J. "Psychogenic" versus "functional" movement disorders? That is the question. Mov Disord. 2014 Nov; 29(13):1697-8. PMID: 25255973.
      Citations: 3     Fields:    Translation:Humans
    276. Thenganatt MA, Jankovic J. Psychogenic tremor: a video guide to its distinguishing features. Tremor Other Hyperkinet Mov (N Y). 2014; 4:253. PMID: 25243097; PMCID: PMC4161970.
      Citations: 12     Fields:    
    277. Jankovic J, Roos RA. Chorea associated with Huntington's disease: to treat or not to treat? Mov Disord. 2014 Sep 15; 29(11):1414-8. PMID: 25156927.
      Citations: 14     Fields:    Translation:Humans
    278. Ramirez-Castaneda J, Jankovic J. Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up. Toxicon. 2014 Nov; 90:344-8. PMID: 25130293.
      Citations: 32     Fields:    Translation:Humans
    279. Evidente VG, Truong D, Jankovic J, Comella CL, Grafe S, Hanschmann A. IncobotulinumtoxinA (Xeomin?) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated. J Neurol Sci. 2014 Nov 15; 346(1-2):116-20. PMID: 25186131.
      Citations: 12     Fields:    Translation:Humans
    280. Deng H, Xiu X, Jankovic J. Genetic convergence of Parkinson's disease and lysosomal storage disorders. Mol Neurobiol. 2015; 51(3):1554-68. PMID: 25099932.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    281. Feng Y, Liu T, Li XQ, Liu Y, Zhu XY, Jankovic J, Pan TH, Wu YC. Neuroprotection by Orexin-A via HIF-1a induction in a cellular model of Parkinson's disease. Neurosci Lett. 2014 Sep 05; 579:35-40. PMID: 25038418.
      Citations: 26     Fields:    Translation:HumansCells
    282. Fernandez HH, Jankovic J, Holds JB, Lin D, Burns J, Verma A, Sethi K, Pappert EJ. Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm. Tremor Other Hyperkinet Mov (N Y). 2014; 4:238. PMID: 25120942; PMCID: PMC4107228.
      Citations: 4     Fields:    
    283. McGrath LM, Yu D, Marshall C, Davis LK, Thiruvahindrapuram B, Li B, Gerber G, Wolf A, Schroeder FA, Osiecki L, O'Dushlaine C, Kirby A, Illmann C, Haddad S, Gallagher P, Fagerness JA, Barr CL, Benarroch F, Bienvenu OJ, Black DW, Bloch MH, Bruun RD, Budman CL, Cath DC, Cavallini MC, Chouinard S, Coric V, Cullen B, Delorme R, Denys D, Derks EM, Dion Y, Eapen V, Evans P, Falkai P, Fernandez TV, Geller D, Grabe HJ, Grados MA, Greenberg BD, Gross-Tsur V, Heiman GA, Hemmings SM, Jankovic J, Kennedy JL, King RA, Kurlan R, Lanzagorta N, Leckman JF, Lennertz L, Lochner C, Lowe TL, Lyon GJ, Macciardi F, Maier W, McCracken JT, McMahon W, Murphy DL, Naarden AL, Neale BM, Nurmi E, Pakstis AJ, Pato MT, Pato CN, Piacentini J, Pittenger C, Pollak Y, Reus VI, Richter MA, Riddle M, Robertson MM, Rosenberg D, Rouleau GA, Ruhrmann S, Samuels J, Sandor P, Sheppard B, Singer HS, Smit JH, Stein DJ, Tischfield JA, Veenstra-VanderWeele J, Wang Y, Wendland JR, Shugart YY, Nicolini H, Oostra BA, Moessner R, Wagner M, Ruiz-Linares A, Heutink P, Nestadt G, Freimer N, Petryshen T, Posthuma D, Jenike MA, Cox NJ, Hanna GL, Scherer SW, Arnold PD, Stewart SE, Mathews CA, Knowles JA, Cook EH, Pauls DL, Wang K, Scharf JM, Cappi C, Bellodi L, Camarena B, Ros?rio MC, Garrido H, Gr?nblatt E, Herrera LD, Hounie AG, Leboyer M, Sampaio AS, Vallada H, Walitza S, Miguel EC, Brentani H. Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. J Am Acad Child Adolesc Psychiatry. 2014 Aug; 53(8):910-9. PMID: 25062598; PMCID: PMC4218748.
      Citations: 54     Fields:    Translation:Humans
    284. DiLorenzo DJ, Jankovic J, Simpson RK, Takei H, Powell SZ. Neurohistopathological findings at the electrode-tissue interface in long-term deep brain stimulation: systematic literature review, case report, and assessment of stimulation threshold safety. Neuromodulation. 2014 Jul; 17(5):405-18; discussion 418. PMID: 24947418.
      Citations: 7     Fields:    Translation:Humans
    285. Deng H, Gao K, Jankovic J. The role of FUS gene variants in neurodegenerative diseases. Nat Rev Neurol. 2014 Jun; 10(6):337-48. PMID: 24840975.
      Citations: 114     Fields:    Translation:Humans
    286. Goldman SM, Kamel F, Ross GW, Jewell SA, Marras C, Hoppin JA, Umbach DM, Bhudhikanok GS, Meng C, Korell M, Comyns K, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Sandler DP, Langston JW, Tanner CM. Peptidoglycan recognition protein genes and risk of Parkinson's disease. Mov Disord. 2014 Aug; 29(9):1171-80. PMID: 24838182; PMCID: PMC4777298.
      Citations: 19     Fields:    Translation:Humans
    287. Patel N, Hanfelt J, Marsh L, Jankovic J, members of the Dystonia Coalition. Alleviating manoeuvres (sensory tricks) in cervical dystonia. J Neurol Neurosurg Psychiatry. 2014 Aug; 85(8):882-4. PMID: 24828895; PMCID: PMC4871143.
      Citations: 29     Fields:    Translation:Humans
    288. Charles PD, Adler CH, Stacy M, Comella C, Jankovic J, Manack Adams A, Schwartz M, Brin MF. Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy). J Neurol. 2014 Jul; 261(7):1309-19. PMID: 24752807; PMCID: PMC4098041.
      Citations: 21     Fields:    Translation:Humans
    289. Thenganatt MA, Jankovic J. Parkinson disease subtypes. JAMA Neurol. 2014 Apr; 71(4):499-504. PMID: 24514863.
      Citations: 147     Fields:    Translation:Humans
    290. Jankovic J, Berkovich E, Eyal E, Tolosa E. Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: post-hoc analyses from the ADAGIO trial. Parkinsonism Relat Disord. 2014 Jun; 20(6):640-3. PMID: 24637126.
      Citations: 11     Fields:    Translation:Humans
    291. Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK. Reply: dystonia after severe head injuries. Mov Disord. 2014 Apr; 29(4):578-9. PMID: 24590449.
      Citations:    Fields:    Translation:Humans
    292. Le W, Sayana P, Jankovic J. Animal models of Parkinson's disease: a gateway to therapeutics? Neurotherapeutics. 2014 Jan; 11(1):92-110. PMID: 24158912; PMCID: PMC3899493.
      Citations: 32     Fields:    Translation:HumansAnimals
    293. Galpern WR, Coffey CS, Albanese A, Cheung K, Comella CL, Ecklund DJ, Fahn S, Jankovic J, Kieburtz K, Lang AE, McDermott MP, Shefner JM, Teller JK, Thompson JL, Yeatts SD, Jinnah HA. Designing clinical trials for dystonia. Neurotherapeutics. 2014 Jan; 11(1):117-27. PMID: 24282121; PMCID: PMC3899487.
      Citations: 8     Fields:    Translation:Humans
    294. Factor SA, Jankovic J. Editorial: Neurotherapeutics of movement disorders. Neurotherapeutics. 2014 Jan; 11(1):3-5. PMID: 24366609; PMCID: PMC3899485.
      Citations:    Fields:    Translation:HumansAnimals
    295. Thenganatt MA, Jankovic J. Treatment of dystonia. Neurotherapeutics. 2014 Jan; 11(1):139-52. PMID: 24142590; PMCID: PMC3899473.
      Citations: 20     Fields:    Translation:Humans
    296. Patel N, Jankovic J, Hallett M. Sensory aspects of movement disorders. Lancet Neurol. 2014 Jan; 13(1):100-12. PMID: 24331796; PMCID: PMC4759644.
      Citations: 97     Fields:    Translation:HumansAnimals
    297. Jankovic J, Baizabal-Carvallo JF. The clinical features of psychogenic movement disorders resembling tics. J Neurol Neurosurg Psychiatry. 2014 May; 85(5):573-5. PMID: 24259592.
      Citations: 26     Fields:    Translation:Humans
    298. Defazio G, Jankovic J, Giel JL, Papapetropoulos S. Descriptive epidemiology of cervical dystonia. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 24255801; PMCID: PMC3822401.
      Citations: 46     Fields:    
    299. Davis LK, Yu D, Keenan CL, Gamazon ER, Konkashbaev AI, Derks EM, Neale BM, Yang J, Lee SH, Evans P, Barr CL, Bellodi L, Benarroch F, Berrio GB, Bienvenu OJ, Bloch MH, Blom RM, Bruun RD, Budman CL, Camarena B, Campbell D, Cappi C, Cardona Silgado JC, Cath DC, Cavallini MC, Chavira DA, Chouinard S, Conti DV, Cook EH, Coric V, Cullen BA, Deforce D, Delorme R, Dion Y, Edlund CK, Egberts K, Falkai P, Fernandez TV, Gallagher PJ, Garrido H, Geller D, Girard SL, Grabe HJ, Grados MA, Greenberg BD, Gross-Tsur V, Haddad S, Heiman GA, Hemmings SM, Hounie AG, Illmann C, Jankovic J, Jenike MA, Kennedy JL, King RA, Kremeyer B, Kurlan R, Lanzagorta N, Leboyer M, Leckman JF, Lennertz L, Liu C, Lochner C, Lowe TL, Macciardi F, McCracken JT, McGrath LM, Mesa Restrepo SC, Moessner R, Morgan J, Muller H, Murphy DL, Naarden AL, Ochoa WC, Ophoff RA, Osiecki L, Pakstis AJ, Pato MT, Pato CN, Piacentini J, Pittenger C, Pollak Y, Rauch SL, Renner TJ, Reus VI, Richter MA, Riddle MA, Robertson MM, Romero R, Rosenberg D, Rouleau GA, Ruhrmann S, Ruiz-Linares A, Sampaio AS, Samuels J, Sandor P, Sheppard B, Singer HS, Smit JH, Stein DJ, Strengman E, Tischfield JA, Valencia Duarte AV, Vallada H, Van Nieuwerburgh F, Veenstra-Vanderweele J, Walitza S, Wang Y, Wendland JR, Westenberg HG, Shugart YY, Miguel EC, McMahon W, Wagner M, Nicolini H, Posthuma D, Hanna GL, Heutink P, Denys D, Arnold PD, Oostra BA, Nestadt G, Freimer NB, Pauls DL, Wray NR, Stewart SE, Mathews CA, Knowles JA, Cox NJ, Scharf JM, Ros?rio MC. Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet. 2013 Oct; 9(10):e1003864. PMID: 24204291; PMCID: PMC3812053.
      Citations: 116     Fields:    Translation:Humans
    300. Shen V, Clarence-Smith K, Hunter C, Jankovic J. Safety and Efficacy of Tetrabenazine and Use of Concomitant Medications During Long-Term, Open-Label Treatment of Chorea Associated with Huntington's and Other Diseases. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 24255799; PMCID: PMC3822048.
      Citations: 9     Fields:    
    301. Wijemanne S, Wu LJ, Jankovic J. Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome. Mov Disord. 2014 Jan; 29(1):126-30. PMID: 24150997.
      Citations: 11     Fields:    Translation:Humans
    302. Kagnoff MN, Jimenez-Shahed J, Fekete R, Jankovic J, Baizabal-Carvallo JF. The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond. J Neurol Neurosurg Psychiatry. 2014 May; 85(5):567-72. PMID: 24096713.
      Citations: 52     Fields:    Translation:Humans
    303. Patel AJ, Sarwar AI, Jankovic J, Viswanathan A. Bilateral pallidal deep brain stimulation for X-linked dystonia-parkinsonism. World Neurosurg. 2014 Jul-Aug; 82(1-2):241.e1-4. PMID: 24076056.
      Citations: 10     Fields:    Translation:Humans
    304. Strickland BA, Jimenez-Shahed J, Jankovic J, Viswanathan A. Radiofrequency lesioning through deep brain stimulation electrodes: a pilot study of lesion geometry and temperature characteristics. J Clin Neurosci. 2013 Dec; 20(12):1709-12. PMID: 24035651.
      Citations: 2     Fields:    Translation:Animals
    305. Pahwa R, Lyons KE, Hauser RA, Fahn S, Jankovic J, Pourcher E, Hsu A, O'Connell M, Kell S, Gupta S, APEX-PD Investigators. Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease. Parkinsonism Relat Disord. 2014 Feb; 20(2):142-8. PMID: 24055014.
      Citations: 34     Fields:    Translation:Humans
    306. Mehanna R, Jankovic J. Restless legs syndrome and cerebrovascular disease - authors' reply. Lancet Neurol. 2013 Aug; 12(8):734-5. PMID: 23867192.
      Citations:    Fields:    Translation:HumansAnimals
    307. Ramirez-Castaneda J, Jankovic J, Comella C, Dashtipour K, Fernandez HH, Mari Z. Diffusion, spread, and migration of botulinum toxin. Mov Disord. 2013 Nov; 28(13):1775-83. PMID: 23868503.
      Citations: 46     Fields:    Translation:HumansAnimals
    308. Waln O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 23858394; PMCID: PMC3709416.
      Citations: 64     Fields:    
    309. Louis ED, Bain PG, Hallett M, Jankovic J, Vonsattel JP. What is It? Difficult to Pigeon Hole Tremor: a Clinical-Pathological Study of a Man with Jaw Tremor. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 23864988; PMCID: PMC3712322.
      Citations:    Fields:    
    310. Jankovic J. Medical treatment of dystonia. Mov Disord. 2013 Jun 15; 28(7):1001-12. PMID: 23893456.
      Citations: 52     Fields:    Translation:Humans
    311. Fernandez HH, Pagan F, Danisi F, Greeley D, Jankovic J, Verma A, Sethi K, Pappert EJ, XCiDaBLE Study Group. Prospective Study Evaluating IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm: Interim Results from the First 145 Subjects with Cervical Dystonia. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 23724362; PMCID: PMC3638085.
      Citations: 10     Fields:    
    312. Jankovic J, Feld J, Baizabal-Carvallo JF. Flu-like symptoms and associated immunological response following therapy with botulinum toxins. Neurotox Res. 2013 Aug; 24(2):298-306. PMID: 23677449.
      Citations: 7     Fields:    Translation:Humans
    313. Jankovic J, Baizabal-Carvallo JF. Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism. Neuromodulation. 2014 Jan; 17(1):104-6. PMID: 23663196.
      Citations: 3     Fields:    Translation:Humans
    314. Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013 Jun 15; 28(7):863-73. PMID: 23649720; PMCID: PMC3729880.
      Citations: 584     Fields:    Translation:Humans
    315. Waln O, Jankovic J. Zolpidem improves tardive dyskinesia and akathisia. Mov Disord. 2013 Oct; 28(12):1748-9. PMID: 23637028.
      Citations: 13     Fields:    Translation:Humans
    316. Killoran A, Biglan KM, Jankovic J, Eberly S, Kayson E, Oakes D, Young AB, Shoulson I. Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS. Neurology. 2013 May 28; 80(22):2022-7. PMID: 23624566; PMCID: PMC3716408.
      Citations: 25     Fields:    Translation:HumansCells
    317. Mehanna R, Jankovic J. Movement disorders in cerebrovascular disease. Lancet Neurol. 2013 Jun; 12(6):597-608. PMID: 23602779.
      Citations: 63     Fields:    Translation:HumansAnimals
    318. Fernandez HH, Pappert EJ, Comella CL, Evidente VG, Truong DD, Verma A, Jankovic J. Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Na?ve Subjects with Cervical Dystonia. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 23610743; PMCID: PMC3629862.
      Citations: 7     Fields:    
    319. Bonnet C, Jankovic J, Baizabal-Carvallo JF. Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome. J Neural Transm (Vienna). 2013 Nov; 120(11):1579-89. PMID: 23580159.
      Citations: 22     Fields:    Translation:Humans
    320. Waln O, Jankovic J. Bilateral globus pallidus internus deep brain stimulation after bilateral pallidotomy in a patient with generalized early-onset primary dystonia. Mov Disord. 2013 Jul; 28(8):1162-3. PMID: 23580321.
      Citations: 3     Fields:    Translation:Humans
    321. Deng H, Gao K, Jankovic J. The VPS35 gene and Parkinson's disease. Mov Disord. 2013 May; 28(5):569-75. PMID: 23536430.
      Citations: 39     Fields:    Translation:HumansAnimals
    322. Dhungana S, Jankovic J. Yips and other movement disorders in golfers. Mov Disord. 2013 May; 28(5):576-81. PMID: 23519739.
      Citations: 11     Fields:    Translation:Humans
    323. Mehanna R, Jankovic J. Movement disorders in multiple sclerosis and other demyelinating diseases. J Neurol Sci. 2013 May 15; 328(1-2):1-8. PMID: 23522528.
      Citations: 21     Fields:    Translation:Humans
    324. Truong DD, Gollomp SM, Jankovic J, LeWitt PA, Marx M, Hanschmann A, Fernandez HH, Xeomin US Blepharospasm Study Group. Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(?)) injections in blepharospasm. J Neural Transm (Vienna). 2013 Sep; 120(9):1345-53. PMID: 23435927; PMCID: PMC3751217.
      Citations: 17     Fields:    Translation:Humans
    325. Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale. Mov Disord. 2013 May; 28(5):668-70. PMID: 23408503.
      Citations: 220     Fields:    Translation:Humans
    326. Stocco A, Muscal E, Jankovic J, Baizabal-Carvallo JF. The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord. 2013 Apr; 28(4):543-7. PMID: 23400857.
      Citations: 32     Fields:    Translation:Humans
    327. Hallett M, Albanese A, Dressler D, Segal KR, Simpson DM, Truong D, Jankovic J. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon. 2013 Jun 01; 67:94-114. PMID: 23380701.
      Citations: 74     Fields:    Translation:Humans
    328. Ramirez-Castaneda J, Jankovic J. Long-term efficacy and safety of botulinum toxin injections in dystonia. Toxins (Basel). 2013 Feb 04; 5(2):249-66. PMID: 23381141; PMCID: PMC3640534.
      Citations: 31     Fields:    Translation:Humans
    329. Deng H, Liang H, Jankovic J. F-box only protein 7 gene in parkinsonian-pyramidal disease. JAMA Neurol. 2013 Jan; 70(1):20-4. PMID: 23318512.
      Citations: 19     Fields:    Translation:Humans
    330. Schneider SA, Dusek P, Hardy J, Westenberger A, Jankovic J, Bhatia KP. Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA). Curr Neuropharmacol. 2013 Jan; 11(1):59-79. PMID: 23814539; PMCID: PMC3580793.
      Citations: 45     Fields:    
    331. Mehanna R, Hunter C, Davidson A, Jimenez-Shahed J, Jankovic J. Analysis of CYP2D6 genotype and response to tetrabenazine. Mov Disord. 2013 Feb; 28(2):210-5. PMID: 23280482.
      Citations: 13     Fields:    Translation:Humans
    332. Mehanna R, Jankovic J. Respiratory disorders associated with dystonia. Mov Disord. 2012 Dec; 27(14):1816-9. PMID: 23208724.
      Citations: 4     Fields:    Translation:Humans
    333. Naumann M, Dressler D, Hallett M, Jankovic J, Schiavo G, Segal KR, Truong D. Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders. Toxicon. 2013 Jun 01; 67:141-52. PMID: 23178324.
      Citations: 17     Fields:    Translation:Humans
    334. Baizabal-Carvallo JF, Jankovic J. Spinocerebellar ataxia types 2 and 10: more than a coincidental association? Arch Neurol. 2012 Nov; 69(11):1524-5; Author reply 1525. PMID: 23117922.
      Citations: 1     Fields:    Translation:Humans
    335. Elble R, Comella C, Fahn S, Hallett M, Jankovic J, Juncos JL, Lewitt P, Lyons K, Ondo W, Pahwa R, Sethi K, Stover N, Tarsy D, Testa C, Tintner R, Watts R, Zesiewicz T. Reliability of a new scale for essential tremor. Mov Disord. 2012 Oct; 27(12):1567-9. PMID: 23032792; PMCID: PMC4157921.
      Citations: 56     Fields:    Translation:Humans
    336. Ferrara JM, Mostile G, Hunter C, Adam OR, Jankovic J. Effect of tetrabenazine on motor function in patients with huntington disease. Neurol Ther. 2012 Dec; 1(1):5. PMID: 26000211; PMCID: PMC4389035.
      Citations: 4     
    337. Squitieri F, Jankovic J. Huntington's disease: how intermediate are intermediate repeat lengths? Mov Disord. 2012 Dec; 27(14):1714-7. PMID: 23008174.
      Citations: 15     Fields:    Translation:HumansCells
    338. Pan T, Zhu J, Hwu WJ, Jankovic J. The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells. PLoS One. 2012; 7(9):e45183. PMID: 23028833; PMCID: PMC3446957.
      Citations: 40     Fields:    Translation:HumansCells
    339. Ondo WG, Jankovic J, Simpson R, Jimenez-Shahed J. Globus pallidus deep brain stimulation for refractory idiopathic restless legs syndrome. Sleep Med. 2012 Oct; 13(9):1202-4. PMID: 22995627.
      Citations: 5     Fields:    Translation:Humans
    340. Zhang Z, Li X, Xie WJ, Tuo H, Hintermann S, Jankovic J, Le W. Anti-parkinsonian effects of Nurr1 activator in ubiquitin-proteasome system impairment induced animal model of Parkinson's disease. CNS Neurol Disord Drug Targets. 2012 Sep; 11(6):768-73. PMID: 22483304.
      Citations: 15     Fields:    Translation:AnimalsCells
    341. Guo Y, Deng X, Jankovic J, Su L, Zhang J, Le W, Xu H, Yang Z, Tang J, Kuang S, Deng H. Mutation screening of the HTR2B gene in patients with Tourette syndrome. Neurosci Lett. 2012 Sep 27; 526(2):150-3. PMID: 22917605.
      Citations: 2     Fields:    Translation:Humans
    342. Fekete R, Davidson A, Jankovic J. Clinical assessment of the effect of tetrabenazine on functional scales in huntington disease: a pilot open label study. Tremor Other Hyperkinet Mov (N Y). 2012; 2. PMID: 23439575; PMCID: PMC3569975.
      Citations: 1     Fields:    
    343. Mahlknecht P, Jankovic J, Poewe W. Emerging therapies for Parkinson's disease. Curr Opin Neurol. 2012 Aug; 25(4):448-59. PMID: 22772874.
      Citations: 23     Fields:    Translation:Humans
    344. Jankovic J, Poewe W. Therapies in Parkinson's disease. Curr Opin Neurol. 2012 Aug; 25(4):433-47. PMID: 22691758.
      Citations: 54     Fields:    Translation:Humans
    345. Jankovic J. Current concepts in Parkinson's disease and other movement disorders. Curr Opin Neurol. 2012 Aug; 25(4):429-32. PMID: 22772873.
      Citations: 2     Fields:    Translation:Humans
    346. Mostile G, Almaguer M, Davidson A, Simpson R, Jankovic J, Baizabal Carvallo JF. Deep brain stimulation hardware complications in patients with movement disorders: risk factors and clinical correlations. Stereotact Funct Neurosurg. 2012; 90(5):300-6. PMID: 22797749.
      Citations: 17     Fields:    Translation:Humans
    347. Kansara S, Trivedi A, Chen S, Jankovic J, Le W. Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed? J Neural Transm (Vienna). 2013 Jan; 120(1):197-210. PMID: 22733089.
      Citations: 4     Fields:    Translation:Humans
    348. Viswanathan A, Jimenez-Shahed J, Jankovic J, Baizabal Carvallo JF. Deep brain stimulation for Tourette syndrome: target selection. Stereotact Funct Neurosurg. 2012; 90(4):213-24. PMID: 22699684.
      Citations: 31     Fields:    Translation:Humans
    349. Fekete R, Jankovic J. Childhood stiff-person syndrome improved with rituximab. Case Rep Neurol. 2012 May; 4(2):92-6. PMID: 22740823; PMCID: PMC3383307.
      Citations: 11     
    350. Marshall DF, Strutt AM, Williams AE, Simpson RK, Jankovic J, York MK. Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Eur J Neurol. 2012 Dec; 19(12):1525-31. PMID: 22632922.
      Citations: 11     Fields:    Translation:Humans
    351. Mostile G, Fekete R, Giuffrida JP, Yaltho T, Davidson A, Nicoletti A, Zappia M, Jankovic J. Amplitude fluctuations in essential tremor. Parkinsonism Relat Disord. 2012 Aug; 18(7):859-63. PMID: 22591578.
      Citations: 17     Fields:    Translation:Humans
    352. Jankovic J, Baizabal-Carvallo JF. Movement disorders in autoimmune diseases. Mov Disord. 2012 Jul; 27(8):935-46. PMID: 22555904.
      Citations: 32     Fields:    Translation:Humans
    353. Deng H, Gao K, Jankovic J. The genetics of Tourette syndrome. Nat Rev Neurol. 2012 Mar 13; 8(4):203-13. PMID: 22410579.
      Citations: 31     Fields:    Translation:Humans
    354. Elmer LW, Surmann E, Boroojerdi B, Jankovic J. Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: a prospective, open-label extension study. Parkinsonism Relat Disord. 2012 Jun; 18(5):488-93. PMID: 22326237.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    355. Ha AD, Beck CA, Jankovic J. Intermediate CAG Repeats in Huntington's Disease: Analysis of COHORT. Tremor Other Hyperkinet Mov (N Y). 2012; 2. PMID: 23440000; PMCID: PMC3569951.
      Citations: 13     Fields:    
    356. Li XP, Xie WJ, Zhang Z, Kansara S, Jankovic J, Le WD. A mechanistic study of proteasome inhibition-induced iron misregulation in dopamine neuron degeneration. Neurosignals. 2012; 20(4):223-36. PMID: 22269801.
      Citations: 10     Fields:    Translation:HumansCells
    357. Dusek P, Jankovic J, Le W. Iron dysregulation in movement disorders. Neurobiol Dis. 2012 Apr; 46(1):1-18. PMID: 22266337.
      Citations: 57     Fields:    Translation:HumansAnimals
    358. Okun MS, Gallo BV, Mandybur G, Jagid J, Foote KD, Revilla FJ, Alterman R, Jankovic J, Simpson R, Junn F, Verhagen L, Arle JE, Ford B, Goodman RR, Stewart RM, Horn S, Baltuch GH, Kopell BH, Marshall F, Peichel D, Pahwa R, Lyons KE, Vitek JL, Tagliati M, SJM DBS Study Group, Tr?ster AI. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. Lancet Neurol. 2012 Feb; 11(2):140-9. PMID: 22239915.
      Citations: 117     Fields:    Translation:Humans
    359. Goldman SM, Kamel F, Ross GW, Jewell SA, Bhudhikanok GS, Umbach D, Marras C, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Meng C, Korell M, Roucoux DF, Hoppin JA, Sandler DP, Langston JW, Tanner CM. Head injury, a-synuclein Rep1, and Parkinson's disease. Ann Neurol. 2012 Jan; 71(1):40-8. PMID: 22275250; PMCID: PMC3270814.
      Citations: 31     Fields:    Translation:HumansCells
    360. Lee HY, Huang Y, Bruneau N, Roll P, Roberson ED, Hermann M, Quinn E, Maas J, Edwards R, Ashizawa T, Baykan B, Bhatia K, Bressman S, Bruno MK, Brunt ER, Caraballo R, Echenne B, Fejerman N, Frucht S, Gurnett CA, Hirsch E, Houlden H, Jankovic J, Lee WL, Lynch DR, Mohammed S, Nespeca MP, Renner D, Rochette J, Rudolf G, Saiki S, Soong BW, Swoboda KJ, Tucker S, Wood N, Hanna M, Bowcock AM, Szepetowski P, Fu YH, M?ller U, Pt?cek LJ. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep. 2012 Jan 26; 1(1):2-12. PMID: 22832103; PMCID: PMC3334308.
      Citations: 96     Fields:    Translation:HumansAnimalsCells
    361. Lees A, Fahn S, Eggert KM, Jankovic J, Lang A, Micheli F, Mouradian MM, Oertel WH, Olanow CW, Poewe W, Rascol O, Tolosa E, Squillacote D, Kumar D. Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease. Mov Disord. 2012 Feb; 27(2):284-8. PMID: 22161845.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    362. Oshima M, Deitiker PR, Jankovic J, Duane DD, Aoki KR, Atassi MZ. Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B. J Neuroimmunol. 2011 Dec 15; 240-241:121-8. PMID: 22079193.
      Citations: 4     Fields:    Translation:HumansCells
    363. Jankovic J, Adler CH, Charles PD, Comella C, Stacy M, Schwartz M, Sutch SM, Brin MF, Papapetropoulos S. Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE). BMC Neurol. 2011 Nov 04; 11:140. PMID: 22054223; PMCID: PMC3220636.
      Citations: 11     Fields:    Translation:Humans
    364. Jankovic J, Clarence-Smith K. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders. Expert Rev Neurother. 2011 Nov; 11(11):1509-23. PMID: 22014129.
      Citations: 33     Fields:    Translation:Humans
    365. Patel SS, Jankovic J, Hood AJ, Jeter CB, Sereno AB. Reflexive and volitional saccades: biomarkers of Huntington disease severity and progression. J Neurol Sci. 2012 Feb 15; 313(1-2):35-41. PMID: 22018763; PMCID: PMC3254798.
      Citations: 14     Fields:    Translation:Humans
    366. Fekete R, Baizabal-Carvallo JF, Ha AD, Davidson A, Jankovic J. Convergence spasm in conversion disorders: prevalence in psychogenic and other movement disorders compared with controls. J Neurol Neurosurg Psychiatry. 2012 Feb; 83(2):202-4. PMID: 21949106.
      Citations: 14     Fields:    Translation:Humans
    367. Ha AD, Jankovic J. Pain in Parkinson's disease. Mov Disord. 2012 Apr; 27(4):485-91. PMID: 21953990.
      Citations: 60     Fields:    Translation:Humans
    368. Jankovic J. Diagnosis and treatment of psychogenic parkinsonism. J Neurol Neurosurg Psychiatry. 2011 Dec; 82(12):1300-3. PMID: 21933950.
      Citations: 12     Fields:    Translation:Humans
    369. Ha AD, Brown CH, York MK, Jankovic J. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsonism Relat Disord. 2011 Sep; 17(8):625-8. PMID: 21689962.
      Citations: 31     Fields:    Translation:Humans
    370. Ha AD, Jankovic J. Exploring the correlates of intermediate CAG repeats in Huntington disease. Postgrad Med. 2011 Sep; 123(5):116-21. PMID: 21904093.
      Citations: 18     Fields:    Translation:HumansCells
    371. Atassi MZ, Jankovic J, Steward LE, Aoki KR, Dolimbek BZ. Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule. Immunobiology. 2012 Jan; 217(1):17-27. PMID: 21962573.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    372. Wu Y, Li X, Zhu JX, Xie W, Le W, Fan Z, Jankovic J, Pan T. Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson's disease. Neurosignals. 2011; 19(3):163-74. PMID: 21778691; PMCID: PMC3699815.
      Citations: 170     Fields:    Translation:HumansAnimalsCells
    373. Comella CL, Jankovic J, Truong DD, Hanschmann A, Grafe S, U.S. XEOMIN Cervical Dystonia Study Group. Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN?, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia. J Neurol Sci. 2011 Sep 15; 308(1-2):103-9. PMID: 21764407.
      Citations: 56     Fields:    Translation:Humans
    374. Oshima M, Deitiker PR, Jankovic J, Duane DD, Aoki KR, Atassi MZ. Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patients. J Neuroimmunol. 2011 Aug 15; 237(1-2):66-72. PMID: 21737146.
      Citations: 2     Fields:    Translation:HumansCells
    375. Simpson R, Jankovic J, Baizabal Carvallo JF. Diagnosis and treatment of complications related to deep brain stimulation hardware. Mov Disord. 2011 Jul; 26(8):1398-406. PMID: 21714001.
      Citations: 11     Fields:    Translation:Humans
    376. Strutt AM, Simpson R, Jankovic J, York MK. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease. Eur J Neurol. 2012 Jan; 19(1):121-7. PMID: 21668586.
      Citations: 21     Fields:    Translation:Humans
    377. Baizabal-Carvallo JF, Jankovic J, Pappert E. Flu-like symptoms following botulinum toxin therapy. Toxicon. 2011 Jul; 58(1):1-7. PMID: 21620881.
      Citations: 10     Fields:    Translation:Humans
    378. Heldman DA, Jankovic J, Vaillancourt DE, Prodoehl J, Elble RJ, Giuffrida JP. Essential tremor quantification during activities of daily living. Parkinsonism Relat Disord. 2011 Aug; 17(7):537-42. PMID: 21570891; PMCID: PMC3137659.
      Citations: 33     Fields:    Translation:Humans
    379. Jankovic J, Comella C, Hanschmann A, Grafe S. Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial. Mov Disord. 2011 Jul; 26(8):1521-8. PMID: 21520284.
      Citations: 21     Fields:    Translation:Humans
    380. van Rooijen DE, Geraedts EJ, Marinus J, Jankovic J, van Hilten JJ. Peripheral trauma and movement disorders: a systematic review of reported cases. J Neurol Neurosurg Psychiatry. 2011 Aug; 82(8):892-8. PMID: 21493756.
      Citations: 31     Fields:    Translation:Humans
    381. Ha AD, Jankovic J. Parkinsonism and dystonia associated with adalimumab. Mov Disord. 2011 Jul; 26(8):1556-8. PMID: 21495070.
      Citations: 1     Fields:    Translation:Humans
    382. Jankovic J, Kurlan R. Tourette syndrome: evolving concepts. Mov Disord. 2011 May; 26(6):1149-56. PMID: 21484868.
      Citations: 43     Fields:    Translation:Humans
    383. Rascol O, Fitzer-Attas CJ, Hauser R, Jankovic J, Lang A, Langston JW, Melamed E, Poewe W, Stocchi F, Tolosa E, Eyal E, Weiss YM, Olanow CW. A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. Lancet Neurol. 2011 May; 10(5):415-23. PMID: 21482191.
      Citations: 60     Fields:    Translation:Humans
    384. Yaltho TC, Jankovic J. The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms. Mov Disord. 2011 Aug 01; 26(9):1582-92. PMID: 21469208.
      Citations: 45     Fields:    Translation:Humans
    385. Guo Y, Le WD, Jankovic J, Yang HR, Xu HB, Xie WJ, Song Z, Deng H. Systematic genetic analysis of the PITX3 gene in patients with Parkinson disease. Mov Disord. 2011 Aug 01; 26(9):1729-32. PMID: 21469209.
      Citations: 3     Fields:    Translation:Humans
    386. Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Edwards KL, Snapinn KW, Goldstein DS, Shi M, Zhang J. Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy. Am J Pathol. 2011 Apr; 178(4):1509-16. PMID: 21435440; PMCID: PMC3078443.
      Citations: 43     Fields:    Translation:Humans
    387. Pan T, Li X, Jankovic J. The association between Parkinson's disease and melanoma. Int J Cancer. 2011 May 15; 128(10):2251-60. PMID: 21207412.
      Citations: 44     Fields:    Translation:Humans
    388. Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, Wang Y, Aasly J, Goldstein D, Zhang J. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol. 2011 Mar; 69(3):570-80. PMID: 21400565; PMCID: PMC3117674.
      Citations: 185     Fields:    Translation:HumansCells
    389. Squitieri F, Esmaeilzadeh M, Ciarmiello A, Jankovic J. Caudate glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG(33) repeat length in the Huntington's disease gene. Mov Disord. 2011 Apr; 26(5):925-7. PMID: 21370274.
      Citations: 7     Fields:    Translation:HumansCells
    390. Fekete R, Jankovic J. Revisiting the relationship between essential tremor and Parkinson's disease. Mov Disord. 2011 Feb 15; 26(3):391-8. PMID: 21462256.
      Citations: 30     Fields:    Translation:Humans
    391. Williams AE, Arzola GM, Strutt AM, Simpson R, Jankovic J, York MK. Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord. 2011 Jun; 17(5):321-7. PMID: 21316292; PMCID: PMC3109216.
      Citations: 30     Fields:    Translation:Humans
    392. Jankovic J, Ha AD. An introduction to dyskinesia--the clinical spectrum. Int Rev Neurobiol. 2011; 98:1-29. PMID: 21907081.
      Citations: 4     Fields:    Translation:Humans
    393. Wu Y, Le W, Jankovic J. Preclinical biomarkers of Parkinson disease. Arch Neurol. 2011 Jan; 68(1):22-30. PMID: 21220674.
      Citations: 49     Fields:    Translation:HumansAnimals
    394. Ferrara J, Stamey W, Strutt AM, Adam OR, Jankovic J. Transcutaneous electrical stimulation (TENS) for psychogenic movement disorders. J Neuropsychiatry Clin Neurosci. 2011; 23(2):141-8. PMID: 21677241.
      Citations: 7     Fields:    Translation:Humans
    395. Atassi MZ, Dolimbek BZ, Jankovic J, Steward LE, Aoki KR. Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies. Immunobiology. 2011 Jul; 216(7):782-92. PMID: 21281977.
      Citations: 9     Fields:    Translation:HumansCells
    396. Li X, Jankovic J, Le W. Iron chelation and neuroprotection in neurodegenerative diseases. J Neural Transm (Vienna). 2011 Mar; 118(3):473-7. PMID: 21161300.
      Citations: 28     Fields:    Translation:HumansCells
    397. Montine TJ, Shi M, Quinn JF, Peskind ER, Craft S, Ginghina C, Chung KA, Kim H, Galasko DR, Jankovic J, Zabetian CP, Leverenz JB, Zhang J. CSF A?(42) and tau in Parkinson's disease with cognitive impairment. Mov Disord. 2010 Nov 15; 25(15):2682-5. PMID: 20818673; PMCID: PMC2978754.
      Citations: 88     Fields:    Translation:Humans
    398. Wu Y, Davidson AL, Pan T, Jankovic J. Asian over-representation among patients with hemifacial spasm compared to patients with cranial-cervical dystonia. J Neurol Sci. 2010 Nov 15; 298(1-2):61-3. PMID: 20864122.
      Citations: 12     Fields:    Translation:Humans
    399. Yaltho TC, Jankovic J, Lotze T. The association of Tourette syndrome and dopa-responsive dystonia. Mov Disord. 2011 Feb 01; 26(2):359-60. PMID: 21412842.
      Citations: 5     Fields:    Translation:Humans
    400. Mostile G, Jankovic J. Alcohol in essential tremor and other movement disorders. Mov Disord. 2010 Oct 30; 25(14):2274-84. PMID: 20721919.
      Citations: 19     Fields:    Translation:HumansAnimals
    401. Ondo WG, Adam OR, Jankovic J, Chinnery PF. Dramatic response of facial stereotype/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States. Mov Disord. 2010 Oct 30; 25(14):2470-2. PMID: 20818611.
      Citations: 9     Fields:    Translation:Humans
    402. Marks WJ, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, Turner D, Verhagen L, Bakay R, Watts R, Guthrie B, Jankovic J, Simpson R, Tagliati M, Alterman R, Stern M, Baltuch G, Starr PA, Larson PS, Ostrem JL, Nutt J, Kieburtz K, Kordower JH, Olanow CW. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol. 2010 Dec; 9(12):1164-1172. PMID: 20970382.
      Citations: 248     Fields:    Translation:HumansCellsCTClinical Trials
    403. Jankovic J, Gelineau-Kattner R, Davidson A. Tourette's syndrome in adults. Mov Disord. 2010 Oct 15; 25(13):2171-5. PMID: 20690167.
      Citations: 18     Fields:    Translation:Humans
    404. Guo Y, Jankovic J, Song Z, Yang H, Zheng W, Le W, Tang X, Deng X, Yang Y, Deng S, Luo Z, Deng H. LINGO1 rs9652490 variant in Parkinson disease patients. Neurosci Lett. 2011 Jan 07; 487(2):174-6. PMID: 20951767.
      Citations: 6     Fields:    Translation:Humans
    405. Deitiker PR, Oshima M, Jankovic J, Duane DD, Aoki KR, Atassi MZ. Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian Americans. Autoimmunity. 2011 May; 44(3):167-76. PMID: 20843162.
      Citations: 3     Fields:    Translation:Humans
    406. Mostile G, Giuffrida JP, Adam OR, Davidson A, Jankovic J. Correlation between Kinesia system assessments and clinical tremor scores in patients with essential tremor. Mov Disord. 2010 Sep 15; 25(12):1938-43. PMID: 20623687.
      Citations: 19     Fields:    Translation:Humans
    407. Yaltho TC, Jankovic J, Pe?a MS. Tardive dyskinesia and other movement disorders secondary to aripiprazole. Mov Disord. 2011 Jan; 26(1):147-52. PMID: 20818603.
      Citations: 20     Fields:    Translation:Humans
    408. Xie W, Li X, Li C, Zhu W, Jankovic J, Le W. Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease. J Neurochem. 2010 Oct; 115(1):188-99. PMID: 20649845.
      Citations: 37     Fields:    Translation:AnimalsCells
    409. Mehanna R, Jankovic J. Respiratory problems in neurologic movement disorders. Parkinsonism Relat Disord. 2010 Dec; 16(10):628-38. PMID: 20674459.
      Citations: 38     Fields:    Translation:Humans
    410. Lim J, Sanghera MK, Darbin O, Stewart RM, Jankovic J, Simpson R. Nonlinear temporal organization of neuronal discharge in the basal ganglia of Parkinson's disease patients. Exp Neurol. 2010 Aug; 224(2):542-4. PMID: 20653074.
      Citations: 11     Fields:    Translation:HumansCells
    411. Stocchi F, Rascol O, Kieburtz K, Poewe W, Jankovic J, Tolosa E, Barone P, Lang AE, Olanow CW. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. Ann Neurol. 2010 Jul; 68(1):18-27. PMID: 20582993.
      Citations: 73     Fields:    Translation:Humans
    412. Shi M, Zabetian CP, Hancock AM, Ginghina C, Hong Z, Yearout D, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Leverenz JB, Zhang J. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. Neurosci Lett. 2010 Aug 09; 480(1):78-82. PMID: 20540987; PMCID: PMC2943649.
      Citations: 81     Fields:    Translation:HumansCells
    413. Mejia NI, Jankovic J. Tardive dyskinesia and withdrawal emergent syndrome in children. Expert Rev Neurother. 2010 Jun; 10(6):893-901. PMID: 20518606.
      Citations: 5     Fields:    Translation:Humans
    414. Wu Y, Li X, Xie W, Jankovic J, Le W, Pan T. Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1 alpha and induction of autophagy in SH-SY5Y cells. Neurochem Int. 2010 Oct; 57(3):198-205. PMID: 20546814.
      Citations: 41     Fields:    Translation:HumansCells
    415. Lim J, Sanghera MK, Darbin O, Stewart RM, Jankovic J, Simpson R. Nonlinear temporal organization of neuronal discharge in the basal ganglia of Parkinson's disease patients. Exp Neurol. 2010 May 28. PMID: 20685206.
      Citations:    Fields:    
    416. Okun MS, Lang A, Jankovic J. Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease. Mov Disord. 2010 May 15; 25(7):961-2; author reply 962-3. PMID: 20461816.
      Citations: 4     Fields:    Translation:Humans
    417. Tan EK, Peng R, Teo YY, Tan LC, Angeles D, Ho P, Chen ML, Lin CH, Mao XY, Chang XL, Prakash KM, Liu JJ, Au WL, Le WD, Jankovic J, Burgunder JM, Zhao Y, Wu RM. Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum Mutat. 2010 May; 31(5):561-8. PMID: 20186690.
      Citations: 56     Fields:    Translation:Humans
    418. Jankovic J. Camptocormia, head drop and other bent spine syndromes: heterogeneous etiology and pathogenesis of Parkinsonian deformities. Mov Disord. 2010 Apr 15; 25(5):527-8. PMID: 20425791.
      Citations: 14     Fields:    Translation:Humans
    419. Wider C, Ross OA, Jasinska-Myga B, Kachergus J, Cobb SA, Soto-Ortolaza AI, Behrouz B, Heckman MG, Diehl NN, Testa CM, Wszolek ZK, Uitti RJ, Jankovic J, Louis ED, Clark LN, Rajput A, Farrer MJ, Vilari?o-G?ell C. LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics. 2010 Oct; 11(4):401-8. PMID: 20369371; PMCID: PMC3930084.
      Citations: 56     Fields:    Translation:Humans
    420. Truong D, Brodsky M, Lew M, Brashear A, Jankovic J, Molho E, Orlova O, Timerbaeva S, Global Dysport Cervical Dystonia Study Group. Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia. Parkinsonism Relat Disord. 2010 Jun; 16(5):316-23. PMID: 20359934.
      Citations: 50     Fields:    Translation:Humans
    421. Frank S, Jankovic J. Advances in the pharmacological management of Huntington's disease. Drugs. 2010 Mar 26; 70(5):561-71. PMID: 20329804.
      Citations: 14     Fields:    Translation:HumansAnimals
    422. Fekete R, Jankovic J. Psychogenic chorea associated with family history of Huntington disease. Mov Disord. 2010 Mar 15; 25(4):503-4. PMID: 20063405.
      Citations: 3     Fields:    Translation:Humans
    423. Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain. 2010 Mar; 133(Pt 3):713-26. PMID: 20157014; PMCID: PMC2842513.
      Citations: 268     Fields:    Translation:Humans
    424. DiLorenzo DJ, Jankovic J, Simpson RK, Takei H, Powell SZ. Long-term deep brain stimulation for essential tremor: 12-year clinicopathologic follow-up. Mov Disord. 2010 Jan 30; 25(2):232-8. PMID: 20063387.
      Citations: 10     Fields:    Translation:HumansCells
    425. Deng H, Yang H, Le W, Deng X, Xu H, Xiong W, Zhu S, Xie W, Song Z, Jankovic J. Examination of the MASH1 gene in patients with Parkinson's disease. Biochem Biophys Res Commun. 2010 Feb 19; 392(4):548-50. PMID: 20097173.
      Citations:    Fields:    Translation:Humans
    426. Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, Albin R, Gearing M, Beyer RP, Shi M, Zhang J. Glycoproteomics in neurodegenerative diseases. Mass Spectrom Rev. 2010 Jan-Feb; 29(1):79-125. PMID: 19358229; PMCID: PMC2799547.
      Citations: 36     Fields:    Translation:HumansCells
    427. Jankovic J. Clinical efficacy and tolerability of Xeomin in the treatment of blepharospasm. Eur J Neurol. 2009 Dec; 16 Suppl 2:14-8. PMID: 20002742.
      Citations: 7     Fields:    Translation:Humans
    428. Deng H, Zhu SH, Le WD, Yang HR, Lv HW, Xu HB, Xie WJ, Jankovic J. Examination of the MSX1 gene in patients with Parkinson's disease. Acta Neurol Scand. 2009 Dec; 120(6):442-4. PMID: 19922584.
      Citations:    Fields:    Translation:Humans
    429. Mostile G, Jankovic J. Treatment of dysautonomia associated with Parkinson's disease. Parkinsonism Relat Disord. 2009 Dec; 15 Suppl 3:S224-32. PMID: 20082997.
      Citations: 12     Fields:    Translation:Humans
    430. Deng S, Deng H, Le W, Xu H, Yang H, Deng X, Lv H, Xie W, Zhu S, Jankovic J. Genetic analysis of the NEUROG2 gene in patients with Parkinson's disease. Neurosci Lett. 2010 Jan 14; 468(3):195-7. PMID: 19879328.
      Citations:    Fields:    Translation:Humans
    431. Adam OR, Ferrara JM, Jankovic J. Motor-phonic tic mimicking essential palatal myoclonus. Mov Disord. 2009 Oct 15; 24(13):2030-2. PMID: 19672987.
      Citations: 2     Fields:    Translation:Humans
    432. Zhu W, Li X, Xie W, Luo F, Kaur D, Andersen JK, Jankovic J, Le W. Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration. Neurobiol Dis. 2010 Feb; 37(2):307-13. PMID: 19818853.
      Citations: 20     Fields:    Translation:AnimalsCells
    433. Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, Langston W, Melamed E, Poewe W, Stocchi F, Tolosa E, ADAGIO Study Investigators. A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med. 2009 Sep 24; 361(13):1268-78. PMID: 19776408.
      Citations: 244     Fields:    Translation:Humans
    434. York MK, Wilde EA, Simpson R, Jankovic J. Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. J Neurol Sci. 2009 Dec 15; 287(1-2):159-71. PMID: 19767016; PMCID: PMC2783787.
      Citations: 44     Fields:    Translation:Humans
    435. Adam OR, Ferrara JM, Aguilar Tabora LG, Nashatizadeh MM, Negoita M, Jankovic J. Education research: patient telephone calls in a movement disorders center: lessons in physician-trainee education. Neurology. 2009 Sep 08; 73(10):e50-2. PMID: 19738167.
      Citations: 2     Fields:    Translation:Humans
    436. Ferrara J, Diamond A, Hunter C, Davidson A, Almaguer M, Jankovic J. Impact of STN-DBS on life and health satisfaction in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2010 Mar; 81(3):315-9. PMID: 19726415.
      Citations: 10     Fields:    Translation:Humans
    437. Jankovic J, Jimenez-Shahed J, Brown LW. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry. 2010 Jan; 81(1):70-3. PMID: 19726418.
      Citations: 39     Fields:    Translation:Humans
    438. Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol. 2009 Sep; 8(9):844-56. PMID: 19679276.
      Citations: 48     Fields:    Translation:Humans
    439. Tanner CM, Ross GW, Jewell SA, Hauser RA, Jankovic J, Factor SA, Bressman S, Deligtisch A, Marras C, Lyons KE, Bhudhikanok GS, Roucoux DF, Meng C, Abbott RD, Langston JW. Occupation and risk of parkinsonism: a multicenter case-control study. Arch Neurol. 2009 Sep; 66(9):1106-13. PMID: 19752299.
      Citations: 71     Fields:    Translation:HumansPHPublic Health
    440. Pan T, Rawal P, Wu Y, Xie W, Jankovic J, Le W. Rapamycin protects against rotenone-induced apoptosis through autophagy induction. Neuroscience. 2009 Dec 01; 164(2):541-51. PMID: 19682553.
      Citations: 110     Fields:    Translation:HumansCells
    441. Jankovic J. Movement disorders. Preface. Neurol Clin. 2009 Aug; 27(3):ix-x. PMID: 19555822.
      Citations:    Fields:    Translation:Humans
    442. Jankovic J. Peripherally induced movement disorders. Neurol Clin. 2009 Aug; 27(3):821-32, vii. PMID: 19555833.
      Citations: 21     Fields:    Translation:Humans
    443. Ferrara JM, Kenney C, Davidson AL, Shinawi L, Kissel AM, Jankovic J. Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial. J Neurol Sci. 2009 Oct 15; 285(1-2):195-7. PMID: 19631949.
      Citations: 16     Fields:    Translation:Humans
    444. Ravina B, Elm J, Camicioli R, Como PG, Marsh L, Jankovic J, Weintraub D. The course of depressive symptoms in early Parkinson's disease. Mov Disord. 2009 Jul 15; 24(9):1306-11. PMID: 19412939; PMCID: PMC2788307.
      Citations: 16     Fields:    Translation:Humans
    445. Gupta A, Jankovic J. Spinocerebellar ataxia 8: variable phenotype and unique pathogenesis. Parkinsonism Relat Disord. 2009 Nov; 15(9):621-6. PMID: 19559641.
      Citations: 12     Fields:    Translation:HumansCells
    446. Sitburana O, Wu LJ, Sheffield JK, Davidson A, Jankovic J. Motor overflow and mirror dystonia. Parkinsonism Relat Disord. 2009 Dec; 15(10):758-61. PMID: 19505838.
      Citations: 14     Fields:    Translation:Humans
    447. Le W, Nguyen D, Lin XW, Rawal P, Huang M, Ding Y, Xie W, Deng H, Jankovic J. Transcription factor PITX3 gene in Parkinson's disease. Neurobiol Aging. 2011 Apr; 32(4):750-3. PMID: 19394114.
      Citations: 12     Fields:    Translation:Humans
    448. Tagliati M, Jankovic J, Pagan F, Susatia F, Isaias IU, Okun MS, National Parkinson Foundation DBS Working Group. Safety of MRI in patients with implanted deep brain stimulation devices. Neuroimage. 2009 Aug; 47 Suppl 2:T53-7. PMID: 19376247.
      Citations: 28     Fields:    Translation:Humans
    449. Jankovic J. Atomoxetine for freezing of gait in Parkinson disease. J Neurol Sci. 2009 Sep 15; 284(1-2):177-8. PMID: 19361809.
      Citations: 13     Fields:    Translation:Humans
    450. Mata IF, Hutter CM, de Pancorbo MM, Lezcano E, Huerta C, Blazquez M, Ribacoba R, Guisasola LM, Salvador C, Zarranz JJ, Infante J, Jankovic J, Deng H, Edwards KL, Alvarez V, Zabetian CP, Gonz?lez-Fern?ndez MC, G?mez-Esteban JC. Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain. Neurogenetics. 2009 Oct; 10(4):347-53. PMID: 19308469; PMCID: PMC2821036.
      Citations: 11     Fields:    Translation:Humans
    451. Guo Y, Jankovic J, Zhu S, Le W, Song Z, Xie W, Liao D, Yang H, Deng H. GIGYF2 Asn56Ser and Asn457Thr mutations in Parkinson disease patients. Neurosci Lett. 2009 May 01; 454(3):209-11. PMID: 19429085.
      Citations: 4     Fields:    Translation:Humans
    452. Wijemanne S, Jankovic J. Hemidystonia-hemiatrophy syndrome. Mov Disord. 2009 Mar 15; 24(4):583-9. PMID: 19097182.
      Citations: 7     Fields:    Translation:Humans
    453. Ferrara J, Jankovic J. Acquired hepatocerebral degeneration. J Neurol. 2009 Mar; 256(3):320-32. PMID: 19224314.
      Citations: 22     Fields:    Translation:Humans
    454. Jankovic J, Kenney C, Grafe S, Goertelmeyer R, Comes G. Relationship between various clinical outcome assessments in patients with blepharospasm. Mov Disord. 2009 Feb 15; 24(3):407-13. PMID: 19053054.
      Citations: 39     Fields:    Translation:Humans
    455. Jankovic J, Albanese A, Hallett M. Unique properties of botulinum toxins. Toxicon. 2009 Oct; 54(5):675. PMID: 19470348.
      Citations: 2     Fields:    Translation:Humans
    456. Ferrara J, Jankovic J. Epidemiology and management of essential tremor in children. Paediatr Drugs. 2009; 11(5):293-307. PMID: 19725596.
      Citations: 3     Fields:    Translation:HumansAnimals
    457. Wu LJ, Sitburana O, Davidson A, Jankovic J. Applause sign in Parkinsonian disorders and Huntington's disease. Mov Disord. 2008 Dec 15; 23(16):2307-11. PMID: 18972544.
      Citations: 8     Fields:    Translation:Humans
    458. Jankovic J. Disease-oriented approach to botulinum toxin use. Toxicon. 2009 Oct; 54(5):614-23. PMID: 19073203.
      Citations: 25     Fields:    Translation:Humans
    459. Freeman RD, Zinner SH, Fast DK, Burd LJ, Kano Y, Rothenberger A, Roessner V, Kerbeshian J, Stern JS, Jankovic J, Loughin T, Janik P, Shady G, Robertson MM, Lang AE, Budman C, Magor A, Bruun R, Berlin CM, M?ller-Vahl KR. Coprophenomena in Tourette syndrome. Dev Med Child Neurol. 2009 Mar; 51(3):218-27. PMID: 19183216.
      Citations: 24     Fields:    Translation:Humans
    460. Olanow CW, Hauser RA, Jankovic J, Langston W, Lang A, Poewe W, Tolosa E, Stocchi F, Melamed E, Eyal E, Rascol O. A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics. Mov Disord. 2008 Nov 15; 23(15):2194-201. PMID: 18932271.
      Citations: 43     Fields:    Translation:HumansCTClinical Trials
    461. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N, Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15; 23(15):2129-70. PMID: 19025984.
      Citations: 1634     Fields:    Translation:Humans
    462. Jankovic J. Etiopathogenesis of Parkinson disease: a new beginning? Neuroscientist. 2009 Feb; 15(1):28-35. PMID: 19008336.
      Citations: 23     Fields:    Translation:HumansAnimalsCells
    463. Jankovic J, Ashoori A. Movement disorders in musicians. Mov Disord. 2008 Oct 30; 23(14):1957-65. PMID: 18785647.
      Citations: 19     Fields:    Translation:Humans
    464. Deng H, Le WD, Jankovic J. Genetic study of an American family with DYT3 dystonia (lubag). Neurosci Lett. 2008 Dec 26; 448(2):180-3. PMID: 18952144.
      Citations: 5     Fields:    Translation:HumansCells
    465. Ferrara J, Jankovic J. Psychogenic movement disorders in children. Mov Disord. 2008 Oct 15; 23(13):1875-81. PMID: 18709677.
      Citations: 22     Fields:    Translation:Humans
    466. Hallett M, Evinger C, Jankovic J, Stacy M, BEBRF International Workshop. Update on blepharospasm: report from the BEBRF International Workshop. Neurology. 2008 Oct 14; 71(16):1275-82. PMID: 18852443; PMCID: PMC2676990.
      Citations: 60     Fields:    Translation:HumansAnimals
    467. Atassi MZ, Jankovic J, Dolimbek BZ. Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A. Neurology. 2008 Sep 23; 71(13):1040; author reply 1040-1. PMID: 18809844.
      Citations: 2     Fields:    Translation:Humans
    468. Le W, Pan T, Huang M, Xu P, Xie W, Zhu W, Zhang X, Deng H, Jankovic J. Decreased NURR1 gene expression in patients with Parkinson's disease. J Neurol Sci. 2008 Oct 15; 273(1-2):29-33. PMID: 18684475; PMCID: PMC2572302.
      Citations: 56     Fields:    Translation:Humans
    469. Atassi MZ, Dolimbek BZ, Jankovic J, Steward LE, Aoki KR. Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatment. Mol Immunol. 2008 Sep; 45(15):3878-88. PMID: 18676021.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    470. Stamey W, Davidson A, Jankovic J. Shoulder pain: a presenting symptom of Parkinson disease. J Clin Rheumatol. 2008 Aug; 14(4):253-4. PMID: 18766134.
      Citations: 12     Fields:    Translation:Humans
    471. Jankovic J, Aguilar LG. Current approaches to the treatment of Parkinson's disease. Neuropsychiatr Dis Treat. 2008 Aug; 4(4):743-57. PMID: 19043519; PMCID: PMC2536542.
      Citations: 99     
    472. Brin MF, Comella CL, Jankovic J, Lai F, Naumann M, CD-017 BoNTA Study Group. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay. Mov Disord. 2008 Jul 30; 23(10):1353-60. PMID: 18546321.
      Citations: 65     Fields:    Translation:HumansAnimalsCTClinical Trials
    473. Pan T, Kondo S, Zhu W, Xie W, Jankovic J, Le W. Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement. Neurobiol Dis. 2008 Oct; 32(1):16-25. PMID: 18640276.
      Citations: 94     Fields:    Translation:AnimalsCells
    474. Strutt AM, Lai EC, Jankovic J, Atassi F, Soety EM, Levin HS, Grossman RG, York MK. Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease. Surg Neurol. 2009 May; 71(5):551-8. PMID: 18514283; PMCID: PMC2735757.
      Citations:    Fields:    Translation:Humans
    475. Ashoori A, Jankovic J. Mozart's movements and behaviour: a case of Tourette's syndrome? Postgrad Med J. 2008 Jun; 84(992):313-7. PMID: 18644922.
      Citations:    Fields:    Translation:Humans
    476. Pan T, Zhu W, Zhao H, Deng H, Xie W, Jankovic J, Le W. Nurr1 deficiency predisposes to lactacystin-induced dopaminergic neuron injury in vitro and in vivo. Brain Res. 2008 Jul 30; 1222:222-9. PMID: 18579122.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    477. Molho E, Jankovic J, Lew M. Role of botulinum toxin in the treatment of cervical dystonia. Neurol Clin. 2008 May; 26 Suppl 1:43-53. PMID: 18603167.
      Citations: 3     Fields:    Translation:Humans
    478. Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F, Factor S, Hunt V, Shinaman A, Jankovic J. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease. Clin Neuropharmacol. 2008 May-Jun; 31(3):127-33. PMID: 18520979.
      Citations: 24     Fields:    Translation:Humans
    479. Zhu W, Xie W, Pan T, Jankovic J, Li J, Youdim MB, Le W. Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration. J Neurochem. 2008 Jun; 105(5):1970-8. PMID: 18399960.
      Citations: 21     Fields:    Translation:Animals
    480. Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, Kenney C, Chung KA, Millard SP, Nutt JG, Montine TJ. CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol. 2008 Apr; 129(4):526-9. PMID: 18343778; PMCID: PMC2688655.
      Citations: 107     Fields:    Translation:Humans
    481. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008 Apr; 79(4):368-76. PMID: 18344392.
      Citations: 1217     Fields:    Translation:Humans
    482. Adam OR, Jankovic J. Symptomatic treatment of Huntington disease. Neurotherapeutics. 2008 Apr; 5(2):181-97. PMID: 18394562; PMCID: PMC5084162.
      Citations: 36     Fields:    Translation:Humans
    483. Kuo SH, Kenney C, Jankovic J. Bilateral pedunculopontine nuclei strokes presenting as freezing of gait. Mov Disord. 2008 Mar 15; 23(4):616-9. PMID: 18181207.
      Citations: 14     Fields:    Translation:Humans
    484. Stamey W, Jankovic J. Impulse control disorders and pathological gambling in patients with Parkinson disease. Neurologist. 2008 Mar; 14(2):89-99. PMID: 18332838.
      Citations: 12     Fields:    Translation:Humans
    485. Jankovic J. Are adenosine antagonists, such as istradefylline, caffeine, and chocolate, useful in the treatment of Parkinson's disease? Ann Neurol. 2008 Mar; 63(3):267-9. PMID: 18383071.
      Citations: 7     Fields:    Translation:HumansAnimals
    486. Kenney C, Hunter C, Davidson A, Jankovic J. Metoclopramide, an increasingly recognized cause of tardive dyskinesia. J Clin Pharmacol. 2008 Mar; 48(3):379-84. PMID: 18223146.
      Citations: 19     Fields:    Translation:Humans
    487. Pan S, Rush J, Peskind ER, Galasko D, Chung K, Quinn J, Jankovic J, Leverenz JB, Zabetian C, Pan C, Wang Y, Oh JH, Gao J, Zhang J, Montine T, Zhang J. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform. J Proteome Res. 2008 Feb; 7(2):720-30. PMID: 18186601.
      Citations: 24     Fields:    Translation:HumansCells
    488. Pan T, Kondo S, Le W, Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain. 2008 Aug; 131(Pt 8):1969-78. PMID: 18187492.
      Citations: 214     Fields:    Translation:HumansCells
    489. Deng H, Le W, Shahed J, Xie W, Jankovic J. Mutation analysis of the parkin and PINK1 genes in American Caucasian early-onset Parkinson disease families. Neurosci Lett. 2008 Jan 03; 430(1):18-22. PMID: 18068301.
      Citations: 11     Fields:    Translation:Humans
    490. Dulay MF, Strutt AM, Levin HS, Jankovic J, Lai EC, Grossman RG, York MK. Depressed mood and memory impairment before and after unilateral posteroventral pallidotomy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2008; 20(3):357-63. PMID: 18806240.
      Citations: 1     Fields:    Translation:Humans
    491. Jankovic J. Parkinson's disease and movement disorders: moving forward. Lancet Neurol. 2008 Jan; 7(1):9-11. PMID: 18093549.
      Citations: 11     Fields:    Translation:Humans
    492. Azher SN, Jankovic J. Clinical aspects of progressive supranuclear palsy. Handb Clin Neurol. 2008; 89:461-73. PMID: 18631769.
      Citations:    Fields:    Translation:Humans
    493. May S, Gilman S, Sowell BB, Thomas RG, Stern MB, Colcher A, Tanner CM, Huang N, Novak P, Reich SG, Jankovic J, Ondo WG, Low PA, Sandroni P, Lipp A, Marshall FJ, Wooten F, Shults CW, North American Multiple System Atrophy Study Group. Potential outcome measures and trial design issues for multiple system atrophy. Mov Disord. 2007 Dec; 22(16):2371-7. PMID: 17914727.
      Citations: 28     Fields:    Translation:Humans
    494. Kuo SH, Jankovic J. Tardive gait. Clin Neurol Neurosurg. 2008 Feb; 110(2):198-201. PMID: 17997030.
      Citations: 4     Fields:    Translation:Humans
    495. Ashoori A, Jankovic J. Mozart's movements and behaviour: a case of Tourette's syndrome? J Neurol Neurosurg Psychiatry. 2007 Nov; 78(11):1171-5. PMID: 17940168; PMCID: PMC2117611.
      Citations: 3     Fields:    Translation:Humans
    496. Diamond A, Kenney C, Almaguer M, Jankovic J. Hyperhidrosis due to deep brain stimulation in a patient with essential tremor. Case report. J Neurosurg. 2007 Nov; 107(5):1036-8. PMID: 17977278.
      Citations: 6     Fields:    Translation:Humans
    497. York MK, Dulay M, Macias A, Levin HS, Grossman R, Simpson R, Jankovic J. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2008 Jul; 79(7):789-95. PMID: 17965146.
      Citations: 48     Fields:    Translation:Humans
    498. Wijemanne S, Jankovic J. Hemiparkinsonism-hemiatrophy syndrome. Neurology. 2007 Oct 16; 69(16):1585-94. PMID: 17938368.
      Citations: 5     Fields:    Translation:Humans
    499. Sitburana O, Jankovic J. Focal hand dystonia, mirror dystonia and motor overflow. J Neurol Sci. 2008 Mar 15; 266(1-2):31-3. PMID: 17888455.
      Citations: 12     Fields:    Translation:Humans
    500. Cheung MY, Shahed J, Jankovic J. Malignant Tourette syndrome. Mov Disord. 2007 Sep 15; 22(12):1743-50. PMID: 17566119.
      Citations: 44     Fields:    Translation:Humans
    501. LeWitt PA, Boroojerdi B, MacMahon D, Patton J, Jankovic J. Overnight switch from oral dopaminergic agonists to transdermal rotigotine patch in subjects with Parkinson disease. Clin Neuropharmacol. 2007 Sep-Oct; 30(5):256-65. PMID: 17909303.
      Citations: 10     Fields:    Translation:Humans
    502. Inzelberg R, Jankovic J. Are Parkinson disease patients protected from some but not all cancers? Neurology. 2007 Oct 09; 69(15):1542-50. PMID: 17699801.
      Citations: 44     Fields:    Translation:Humans
    503. Zhu W, Xie W, Pan T, Xu P, Fridkin M, Zheng H, Jankovic J, Youdim MB, Le W. Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators. FASEB J. 2007 Dec; 21(14):3835-44. PMID: 17690154.
      Citations: 37     Fields:    Translation:AnimalsCells
    504. Stamey W, Jankovic J. The other Babinski sign in hemifacial spasm. Neurology. 2007 Jul 24; 69(4):402-4. PMID: 17646635.
      Citations: 13     Fields:    Translation:Humans
    505. York MK, Lai EC, Jankovic J, Macias A, Atassi F, Levin HS, Grossman RG. Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis. Acta Neurochir (Wien). 2007; 149(9):857-66; discussion 866. PMID: 17624489.
      Citations: 8     Fields:    Translation:Humans
    506. Adair JC, Cooke N, Jankovic J. Alexia without agraphia in Creutzfeldt-Jakob disease. J Neurol Sci. 2007 Dec 15; 263(1-2):208-10. PMID: 17628601.
      Citations: 2     Fields:    Translation:Humans
    507. Erer S, Jankovic J. Hereditary chin tremor in Parkinson's disease. Clin Neurol Neurosurg. 2007 Nov; 109(9):784-5. PMID: 17618046.
      Citations: 2     Fields:    Translation:Humans
    508. Jankovic J, Deng H. Candidate locus for chorea and tic disorders at 15q? Pediatr Neurol. 2007 Jul; 37(1):70-3. PMID: 17628228.
      Citations: 3     Fields:    Translation:HumansCells
    509. Kenney C, Diamond A, Mejia N, Davidson A, Hunter C, Jankovic J. Distinguishing psychogenic and essential tremor. J Neurol Sci. 2007 Dec 15; 263(1-2):94-9. PMID: 17604055.
      Citations: 15     Fields:    Translation:Humans
    510. Ravina B, Camicioli R, Como PG, Marsh L, Jankovic J, Weintraub D, Elm J. The impact of depressive symptoms in early Parkinson disease. Neurology. 2007 Jul 24; 69(4):342-7. PMID: 17581943; PMCID: PMC2031220.
      Citations: 86     Fields:    Translation:HumansPHPublic Health
    511. Kenney C, Jankovic J. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm (Vienna). 2008; 115(4):585-91. PMID: 17558461.
      Citations: 24     Fields:    Translation: